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Abstract
Articular cartilage tissue has limited capacity for self-regeneration leading to challenges
in the treatment of joint injuries and diseases such as osteoarthritis. The tissue engineering approach combines biomaterials, cells and bioactive molecules to provide
a long-term and stable cartilage repair. In the following work, electroactive polymer
polypyrrole (PPy) was incorporated into the synthetic hydrogel to enhance the mechanical properties of the material for cartilage applications. PPy was loaded with drug
compound and the on demand drug release was demonstrated. The composite PPy
hydrogel was 3D printed using stereolithography to create a porous tissue engineering
scaffold. Biocompatibility and cell adhesion to the material were investigated to ensure
their applicability in cartilage regenerative applications. Fabricated composite polymers
were successful as potential biomaterials for cartilage tissue engineering scaffolds.

Keywords: cartilage regeneration, polypyrrole, drug delivery, hydrogels, electroactive
polymers, 3D printing.
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Summary for Lay Audience
Cartilage tissue repair presents a significant challenge for clinicians and scientists.
In healthy joints, cartilage acts as a protective layer covering the bone surface and
helps mitigate the high mechanical load joints in the human body are exposed to
daily. When cartilage tissue breaks down due to inflammation or injury to the joint,
the bone surface is left unprotected, leading to high pain levels, and a decrease in
the range of motion ultimately leading to disability. Due to the absence of direct blood
supply, cartilage has a very limited capacity for self-regeneration. Tissue engineering
is a promising approach that can induce and support cartilage repair. It combines
biomaterials providing structural replacement at the site of the defect, cells responsible
for the formation of new tissue, and bioactive molecules that turn on or off certain cell
activities or metabolic processes in the surrounding tissues. Hydrogel biomaterials have
been recognized as being structurally similar to cartilage tissue, however, they have
to be paired with a second polymer for improved functionality. Polypyrrole is a smart
polymer that can store medicinal compounds and release them on demand, making it an
attractive material for biomedical applications. Hydrogel/polypyrrole composite materials
were produced in this study for potential use in cartilage tissue engineering. These
materials were not toxic to cartilaginous cells and even supported their attachment to
the surface. To ensure the functionality of the material, it was tested for drug delivery
capabilities. Moreover, the porous hydrogel/polypyrrole structure was 3D printed and
can be investigated for use in tissue engineering scaffolds.
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Chapter 1
Introduction
Articular cartilage lesions can occur due to traumatic injury to the joint or through the
course of multifactorial joint diseases such as osteoarthritis (OA) (Hunziker, 2002).
Unfortunately, the deterioration of articular cartilage in OA is not reversible, and chondral
defects may penetrate to the bone and require joint replacement surgery (Wei and
Dai, 2021). An additional precipitant to this problem is caused by the limited ability of
cartilage tissue for self-repair and usually failed regeneration at the early stages of the
disease (Wei and Dai, 2021).
Tissue engineering approaches combine biomaterials, cells and growth factors to
generate an environment that can act as a replacement for injured cartilage and stimulate
and support intrinsic regenerative processes. Biomaterials play an essential role as
they are responsible for the mechanical stability of the tissue engineering construct and
create a supportive environment for cells. For cartilage tissue engineering, hydrogels
have been recognized as the one of the most promising biomaterials as they possess
cartilage tissue-like features (Wei and Dai, 2021). Synthetic polymer hydrogels prepared
with poly(ethylene) glycol diacrylate (PEGDA) have been studied and utilized for cartilage
regeneration due to the ease in preparation and processing (Wei and Dai, 2021; Choi
et al., 2019; Nguyen et al., 2013; Musumeci et al., 2011). PEGDA hydrogels have
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the potential to be 3D printed into porous tissue engineering scaffolds using additive
manufacturing technologies for photocurable polymers. However, they lack bioactivity
and are intrinsically inert to cell adhesion and protein adsorption (Wei and Dai, 2021).
The composites of PEGDA hydrogels with another synthetic or natural polymer have
been proposed as a solution to this problem. Combining different materials into a
composite allows superior physical properties and bioactivity (Wei and Dai, 2021).
The electroactive polymer polypyrrole (PPy) possesses a unique organic polymer
property in the form of electrical conductivity. PPy has been extensively studied for use in
tissue engineering as it can promote cell growth through electrical stimulation (Schmidt
et al., 1997; Zhou et al., 2019). Additionally, PPy exhibits reversible electrochemistry,
meaning it can be switched between the conductive and neutral states through the
application of oxidative or reductive electrical potential accompanied by the ionic flow
in and out of the polymer backbone (Schmidt et al., 1997). This property makes
PPy an attractive material for controlled drug delivery applications, as it is capable of
incorporating and releasing complex anionic compounds on demand.
Composite PEGDA-PPy materials have been previously introduced in the literature,
however, they have been rarely studied for applications in drug delivery and regeneration
of cartilage tissue. This thesis is a first-to-date systematic study providing the characterization of composite PEGDA-PPy hydrogels synthesized using interfacial chemical
oxidative polymerization methods, as well as describing their drug delivery ability and
potential for cartilage tissue engineering applications.

1.1

Objectives

This thesis aims to develop a conducting polymer-hydrogel biomaterial that can be
utilized for drug delivery and support the regeneration of articular cartilage. The following
objectives are required to achieve this goal:

Introduction
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• Develop the manufacturing process for a biocompatible PEGDA-PPy biomaterial
It is desirable to control the properties of both components of the composite, and
therefore a manufacturing process was developed to achieve this. In chapter 3
a modification to the interfacial chemical polymerization method is proposed
to achieve higher conductivity, better electrochemical performance and surface
modifications of the composite. Characterization of material was performed to
investigate the impact of the conducting polymer phase on the structure and
physical properties of the composite.
• Develop a resin formulation to allow for 3D printing
The second objective was to tune the PEGDA hydrogel formulation with an addition
of a biocompatible UV-absorber to be used in a custom designed stereolithography
printer in the Organic Mechatronics and Smart Materials Laboratory (OMASML).
Printing parameters were optimized to allow the printing of porous structures to
target the production of tissue engineering scaffolds.
• Develop an in-situ process for drug incorporation
The third objective was to develop the process that allows for drug incorporation
during chemical oxidative polymerization. Drug release experiments are performed
to prove the successful incorporation of the model drug compound and investigate
possible triggers for controlled release.
• Demonstrate the application of the composite biomaterial
The last objective was to demonstrate the application of the developed PEGDAPPy biomaterial for controlled drug release and cell attachment. Time-dependant
release of the model drug compound from the PEGDA-PPy were investigated.
Biocompatibility and bioactivity of the developed composite were also reported.
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Major contributions

This thesis communicates the following major contributions to the scientific community:
• Novel interfacial chemical polymerization methods
This thesis represents first study that describes the modification of the interfacial
chemical polymerization method for the creation of biocompatible PEGDA-PPy
materials with improved physical properties and electrochemical performance.
• A novel PEGDA resin formulation that allows for the creation of porous structures
using 3D printing
The PEGDA resin described in this thesis enables the creation of lattice-like
structures by means of an interfacial chemical polymerization method to obtain
electroactive PEGDA-PPy hydrogels.
• Characterization of the Fluorescein incorporation during chemical oxidative polymerization and its release from PEGDA-PPy materials
Here the first investigation into the doping of PPy during chemical oxidation is
presented. The deprotonation of PPy in an alkaline environment demonstrated
high release rates of the model drug compound and confirmed its incorporation.
This research also provides insight into the pH-sensitivity of PEGDA hydrogels
and Fluorescein and their contribution to drug delivery rates.
• Biocompatibility and cell attachment studies of PEGDA-PPy hydrogels
Biocompatibility of the developed conducting hydrogels was confirmed via tests
with the chondrogenic cell line ATDC5. Improved cell attachment and protein
adsorption to the PEGDA-PPy materials prepared with the novel interfacial polymerization method were demonstrated.
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Organization of the thesis

The following chapter, Chapter 2, Background summarizes the most influential knowledge in cartilage tissue structure, cartilage lesion pathology, and biomaterials used for
cartilage repair. In accordance with the aforementioned objectives, the remainder of the
thesis is organized as follows: Chapter 3, PEGDA-PPy hydrogel fabrication explores
the fabrication and properties of PEGDA hydrogels and novel PEGDA-PPy composites, including the additive manufacturing of a PEGDA-PPy tissue engineering scaffold
model. Next, Chapter 4, Drug delivery from PEGDA-PPy hydrogels explores the drug
delivery capability of PEGDA-PPy biomaterials, specifically outlining the doping process
during interfacial chemical polymerization and pH-sensitive drug release. Chapter 5,
PEGDA-PPy biocompatibility describes biological studies used to validate the absence
of toxicity from PEGDA and PEGDA-PPy hydrogels, and observe cell response to these
materials. Finally, Chapter 6, Concluding remarks summarizes the conclusions of this
work, reiterates the main scientific contributions, and provides recommendations for
future research.
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Chapter 2
Background
The following chapter summarizes pertinent information about the structure and biomechanical characteristics of articular cartilage tissue gathered from the works of Alford
and Cole (2005); Fox et al. (2009); Martinez-Moreno et al. (2019) and Articular Cartilage
chapter of the book by Waters et al. (2018). The etiology and pathology of cartilage
lesions, and challenges associated with cartilage tissue regeneration are discussed
using the information from works by Alford and Cole (2005) and Hunziker (2002). Introduction to tissue engineering as a promising option for cartilage defect treatment is
given. Electroactive conducting polymers (ECPs) are presented as biomaterials used
in tissue engineering and regenerative medicine. Different methods used to fabricate
composite ECP-containing materials are presented. Lastly, synthetic poly(ethylene)
glycol-based hydrogels are discussed as materials used for cartilage tissue regeneration
and drug delivery.
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Cartilage tissue regeneration
Articular cartilage

Articular cartilage is a highly specialized connective tissue in a human body. It performs
two major biomechanical functions in the joints. Firstly, articular cartilage creates a
smooth layer on bone surfaces thus minimizing friction during motion. Secondly, it
distributes compressive and tensile loads to the underlying subchondral bone. Complex
composition and organization of articular cartilage contributes to its unique material
properties that allow the tissue to withstand high constant compressive load.
Articular cartilage is a hyaline cartilage composing of extracellular matrix (ECM,
occupies > 95 % of the tissue) and highly specialized cells called chondrocytes. The
major components of extracellular matrix are water (> 80 % of the wet weight), collagen (type II) and proteoglycans. Negatively charged carboxyl and sulfate groups of
proteoglycans ensure the high hydrophilicity of the ECM.
The content and organization of ECM components varies greatly through the cartilage layer thickness creating four major zones (fig. 2.1). The superficial zone has tightly
packed and horizontally aligned collagen fibers responsible for the tensile properties
of the tissue. The middle layer which occupies most of the tissue volume, contains
cells and obliquely oriented collagen fibers, and serves as a first line of resistance for
compression forces placed on the tissue. The deep zone has the lowest water content,
but the largest proteoglycan concentration and is characterized by the perpendicular
orientation of collagen fibers. This zone is responsible for providing resistance to the
compression forces. The last calcified zone performs as a transition layer between
cartilage and bone.
The excellent resilience of articular cartilage to compressive forces can be explained
by the two-phase nature of the tissue. The porous structure of the solid ECM phase
leads to the distribution of applied load due to the reduction in number of contact points.
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Figure 2.1: The structure of articular cartilage highlighting variations in orientation of the
ECM components throughout the thickness of cartilage. © Setton et al. (1999), included
with permission.
The flow of liquid phase (water) through the solid phase when compressive loads are
applied contributes to the viscoelastic behaviour of the tissue. Low permeability of
cartilage prevents water from being squeezed out of the matrix thus creating high fluid
pressure which reduces the compressive load placed on the solid phase. While water
moves through the charged regions of proteoglycans, it generates piezoelectric charges
that further modulate liquid flow.
Articular cartilage lacks blood and lymphatic vessels, as well as innervation. Diffusion
of nutrients from blood plasma happens mainly through the synovial fluid. The avascular
nature of articular cartilage is greatly responsible for its limited ability to self-repair.
Therefore, cartilage tissue lesions remain hard to treat.

2.1.2

Cartilage lesions

Articular cartilage lesions can occur either because of the injury or due to the degeneration of tissue caused by number of inflammatory joint diseases such as osteoarthritis (OA).
According to the Canadian Arthritis Society, OA is a multifactor pathology affecting
nearly 6 million Canadians (Badley et al., 2019). This disease affects mostly large
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weight-bearing joints in the human body such as knees, hips, lumbar and sacral spine,
leading to significant limitations in mobility due to the subchondral bone sclerosis and
high pain levels. The main pathological feature of OA is an inflammatory breakdown of
the tissue due to action of proteolytic enzymes, followed by the loss of chondrocytes.
Metabolic activity of the remaining cells is altered so that the catabolic processes
prevail over the anabolic. As mentioned above, cartilage lesions have limited capacity
for regeneration. Without specific treatment to suppress inflammatory processes and
catabolic cell acitivity in OA, disease progresses and leads to the growth of the defect
and bone tissue involvement.
However, different kinds of lesions possess various self-repair properties. In partialthickness defects, only articular cartilage in the joint is affected. These injuries are
usually characterized by the disruptions in cell metabolic activity and ECM composition.
Full-thickness and osteochondral defects are deep cartilage defects that penetrate down
to the subchondral bone. Osteochondral defects can penetrate as far as to the bone
marrow. Full-thickness and osteochondral defects have some potential for spontaneous
repair, contributed by the availability of stem cell sources, such as bone marrow, synovial
fluid, blood vessels, adipose tissue and bone itself. These types of defects usually
involve local bleeding and the formation of hematoma, and, subsequently, – fibrous
cartilage tissue. However, this repair tissue has inferior biomechanical properties and
will slowly deteriorate over time.
Currently available treatment options for these defects include surgical interventions
and non-operative conservative therapies used to reduce symptoms and pain. Various
surgical treatments involve the removal of affected tissue, and often stimulation of a
spontaneous tissue healing response through the exposure of bone marrow, bone
tissue (Hunziker, 2002). The most promising non-operative treatment options include
cell-targeted therapies where therapeutic agents are injected to stimulate the buildup of the new cartilage tissues. However, all of them often result in the formation of
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fibrocartilage that lacks mechanical stability to withstand compression loads (Falah et al.,
2010; Jain and Ravikumar, 2020). The knowledge of cartilage structure and lesion
pathology establishes considerations for the design of novel regenerative therapies for
the treatment of cartilage lesions.

2.1.3

Cartilage tissue regeneration

Tissue engineering (TE), which combines biomaterials, cells and growth factors with an
aim of restoration of the tissue, is a promising approach to provide long-term and stable
repair of the cartilage. The basic principle behind TE is a utilization of a biomaterial
matrix (TE scaffold) that provides structural support and biological cues for the cells
during their attachment, proliferation and differentiation (Zhang et al., 2017; Pogorielov
et al., 2017). Growth factors are used to induce or supress certain metabolic processes
in cells thus regulating their behaviour (Jain and Ravikumar, 2020).
The biomaterial matrix plays an important role in TE as it supports and promotes the
growth of the new tissue. The scaffold should be biocompatible, meaning it does not
promote any (or only minimal) immune reaction. The main material requirements are
sufficient porosity – to enable cell migration, nutrient/waste exchange, deformability and
stiffness matching those of the tissue scaffold is aiming to replace (Hunziker, 2002; Jain
and Ravikumar, 2020).
Ideally, the scaffold should be able to stimulate certain biological response from the
cells (Hunziker, 2002; Zhang et al., 2017). This is particularly important for cartilage
regeneration, as biological cues provided by the scaffold should stimulate formation
of the hyaline cartilage as opposed to the fibrocartilage most frequently found at the
place of injury. Additionally, the delivery of growth factors or other biologically active
molecules from TE scaffold can possibly help to abolish inflammatory processes in
OA cartilage lesions. Therefore, in TE, different modification techniques are used for
surface treatments or to bind the material with certain biologically active molecules (e.g.
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cell-adhesion promoting peptides such as RGD peptide) (Bellis, 2011).
Natural polymers (gelatin, collagen, chitosan, etc.) are usually the first choice
for the fabrication of TE scaffolds (Zhang et al., 2017), however, synthetic polymers
(poly(lactic) acid (PLA), poly(glycolic) acid (PGA), polyethylene glycol (PEG)-based,
etc.) demonstrate better processability using additive manufacturing techniques for the
creation of porous complex scaffold architectures (Pogorielov et al., 2017). The following
section 2.2 and section 2.3 describe structural features and properties of electroactive
organic polymers and synthetic hydrogels as promising candidates for tissue engineering
applications.

2.2
2.2.1

Electroactive conjugated polymers (ECPs)
Structure and properties of ECPs

The first conducting organic polymer, polyacetylene, was synthesized and characterized
in 1970 (Shirakawa et al., 1977). The Nobel Prize in Chemistry was awarded to
Alan J. Heeger, Alan G. MacDiarmid and Hideki Shirakawa in 2000 “for the discovery
and development of conductive polymers,” acknowledging the significant impact this
discovery has made on the scientific community (Wan, 2008). As opposed to the majority
of organic polymers, which are excellent insulators, conducting polymers have optical
and physical properties of inorganic semiconductors and metals (Ferrigno et al., 2020).
Since the discovery of polyacetylene, a number of conducting polymers (CPs) such
as polypyrrole (PPy), polyaniline (PANI), and polythiophene have been developed as
illustrated in fig. 2.2 (Holness, 2017). Their most common applications are in sensors
and actuators (Ning et al., 2018); however, many research efforts have sought to utilize
CPs for drug delivery and tissue regeneration.
The conductivity of CPs is enabled through their chemical structure. For example,
polyacetylene, which might be considered the simplest example of a conjugated polymer,
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Figure 2.2: The chemical structure of various conducting polymers. Alternating single
and double carbon bonds in the structure are responsible for the conductivity property.
© Bhadra et al. (2009), included with permission.
has alternating single and double carbon bonds in its structure (fig. 2.2). Double bonds
have overlapping π-electron waves (conjugation) of carbon atoms. These unpaired
electrons can be delocalized through the polymer chain, thus allowing the electron flow
and explaining the conductivity property of CPs (Wan, 2008; Le et al., 2017).
CPs exhibit a wide range of conductivity starting from an insulator (10−10 S · m−1 to
10−8 S · m−1 ), to a semiconductor (10−6 S · m−1 to 10 S · m−1 ) and in some cases even
exhibit metal-like conductivity (104 S · m−1 ). High conductivity is achieved through the
doping process, and conductivity range depends on the degree of doping; conversely, in
the undoped state, CPs behave as electrical insulators (Le et al., 2017). Doping entails
the incorporation of ionic species into the polymer chain. As synthesized, CPs have an
excessive positive charge and require a counter anion to maintain their electrochemical
neutrality (fig. 2.3). Through the incorporation of a counter anion dopant, charge carriers
are also introduced into the system. In case of PPy, charge carriers are called polarons
and bipolarons. Electrons pass through the system when an electric potential is applied,
and dopants move in or out of the polymer chain (Tandon et al., 2018).
Polypyrrole can be synthesized chemically and electrochemically from a pyrrole
monomer. The polymerization mechanism involves the oxidation of pyrrole and coupling
between radical cations (fig. 2.4), (Skotheim and Reynolds, 2006). The electrochemical
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Figure 2.3: The chemical structure of polypyrrole. Anionic dopant is required to balance
out the excessive positive charge of as-synthesized polymer. © Stejskal and Cz (2019),
included with permission.

Figure 2.4: The oxidative polymerization of polypyrrole in the presence of anionic dopant.
© Svirskis et al. (2010), included with permission.
method utilizes the application of an oxidative potential to initiate polymerization. In
the chemical polymerization method, this function is performed by a strong oxidizing
agent such as iron (III) chloride or ammonium persulfate (APS) (Ansari, 2006). The
chemical oxidation method usually results in a precipitation of insoluble PPy powder,
while electrochemical polymerization results in a deposition of PPy films on electrode
surfaces, with both forms lacking mechanical stability (Miar et al., 2021).

2.2.2

Doping, drug incorporation and release

Doping of PPy with other molecules can be performed either chemically or electrochemically. In the case of chemical polymerization, dopants are usually limited to anions
provided by oxidants. Every 3rd or 4th pyrrole unit in the polymer chain needs to be
doped with a dopant anion for electrochemical stability (Ansari, 2006; Wallace et al.,
2002). However, large anionic dopants can be successfully incorporated spontaneously
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in competition with anions arising from the oxidant (Skotheim and Reynolds, 2006;
Wallace et al., 2002). In work by Shen and Wan (1998), PPy was prepared via chemical
oxidation with ammonium persulfate in the presence of different organic sulfonic acids.
The resulting polymer powder was highly conductive and solvable in m-cresol as a result
this approach.
The ability of CPs to uptake or release ionic molecules while being switched between
oxidized and reduced states has been investigated for application in controlled drug
delivery systems (Tandon et al., 2018). When the drug is incorporated into the CP
structure as a dopant, the maximum loading that can be achieved is one drug molecule
per 3 to 5 polymer monomer unints (Uppalapati et al., 2016).
The most studied way of drug doping is an electrochemical method. The medicinal
compound can be loaded into the PPy via the one-step immobilization process during
the electrochemical polymerization in the form of a primary dopant (Tandon et al., 2018).
Successful doping of two clinically relevant drugs: dexamethasone and meropenem, with
PPy during polymer deposition on the indium titan oxide coated glass electrodes was
reported in work by Shah et al. (2018). In a study previously performed in the Organic
Mechatronics and Smart Materials Laboratory (OMASML), Fluorescein (Fl) was successfully loaded into PPy films modified with microstructures during the electrochemical
polymerization (Liubchak et al., 2020).
However, the disadvantages of a one-step method can include low drug loading
capacity, inferior mechanical properties, and possible interferences to the polymerization
process from the drug molecule (Tandon et al., 2018). An alternative to this is a threestep drug immobilization process which includes: 1) an electrochemical synthesis of
PPy with the primary dopant of choice; 2) de-doping of PPy through the application
of reduction potential; and 3) subsequent doping with the medicinal compound in an
electrochemical cell (Tandon et al., 2018). In the study performed by Krukiewicz et al.
(2015), both one-step and three-step drug incorporation methods were investigated
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for their effectiveness in incorporating quercetin and ciprofloxacin. The post-synthesis
approach has resulted in higher drug loading rates than the one-step doping process;
however, the nature of the drug used for doping also played a significant role, as neutral
quercetin was more effectively incorporated through the one-step approach.
Loading drug molecules during oxidative chemical polymerization usually happens
via the one-step process, where a medicinal compound is added to the reaction mixture
containing pyrrole monomer and oxidizer. Drugs are incorporated into the polymer
structure along with the small anionic primary dopant provided by the oxidizer. PPy
nanoparticles prepared via chemical oxidation demonstrated successful incorporation
of anionic Fl and positively charged Rhodamine 6 G (R6G) in work by Samanta et al.
(2015). The same research group also reports the incorporation and controlled release
of clinically relevant protein insulin from PPy nanoparticles (Niloufar Hosseini-Nassab
et al., 2016). Doping anti-tumour agent paclitaxel with PPy via oxidative chemical
polymerization was successful in a study by Tiwari et al. (2018), where the drug was
released using near-red irradiation (NIR) and showed an anticancer efficacy in an in
vitro study with breast cancer cells.
To stimulate drug delivery from PPy, an oxidizing or reducing potential in an electrochemical cell can be applied. For example, electrical stimulation was used to release
dexamethasone and penicillin/streptomycin from PPy films grown on titanium substrate
(Sirivisoot et al., 2011). Almost 80 % of drugs were released using this method. Electrochemical stimulation was also effective for releasing neurotrophin-3, a protein that
promotes the growth of various nerve cells (Thompson et al., 2006).
However, other factors, such as the pH of the environment, have been investigated
as potential drug release triggers as well. The mechanism for the pH-sensitive dopant
release from PPy has been extensively described in work by Samanta et al. (2015). Due
to the excess of the hydrogen ions in as-synthesized PPy, in the alkaline media with
low H+ concentration, the polymer undergoes deprotonation reaction. Excess hydrogen
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is released into the media, followed by the release of an anionic dopant to maintain
polymer stability (Samanta et al., 2015). Based on the elemental analysis data, the
hydrogen content of PPy (NO3 )-films is significantly reduced after they are immersed
in the basic solution (Pei and Qian, 1991). The conductivity of PPy is also decreased
when it’s in the deprotonated state (Prokes et al., 2019).
In the strong acidic media, doped PPy undergoes a protonation reaction, followed by
a slight increase in conductivity. In this case, the overall hydrogen ion content in PPy is
increased, thus raising the overall positive charge of the polymer. This reaction is not
suitable for the release of anionic compounds, moreover, if the media contains anions,
they can be incorporated into PPy along with hydrogen ions to maintain the polymer
chain stability (Pei and Qian, 1991). However, according to Samanta et al. (2015), acidic
pH values caused the repulsion of positively charged R6G due to the excessive positive
charge of the polymer.

2.2.3

PPy for tissue engineering

PPy has been extensively studied for its potential applications in tissue engineering
and regenerative medicine due to its unique chemical and physical structure, surface
topology, and ease of modification (Ateh et al., 2006; Ramanaviciene et al., 2007).
Numerous cell viability studies varying across the range of different body systems
have previously demonstrated that PPy is a biocompatible polymer. For example, the
extraction solutions from chemically synthesized PPy were used on nerve cells and have
shown no impact on cell viability in the study by Wang et al. (2004). Cardiac progenitor
cells isolated from adult mice were cultivated on electrochemically prepared PPy films
doped with various dopants, and have demonstrated high cell counts (Gelmi et al.,
2014). In the in vivo study performed by Ramanaviciene et al. (2007), PPy particles
were injected in mice intraperitoneally and have shown no toxicity. These experimental
results highlight the potential implementation of PPy across the body.
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Incorporation of biologically active molecules such as growth factors, laminin peptides
etc., into the structure of PPy can improve the interactions between CPs and cells
(Green et al., 2010, 2012). In the study done by Li and Yu (2017), PPy films prepared
electrochemically in the presence of RGD peptide (fragment from the laminin protein
necessary for cell attachment) have demonstrated an improved adhesion and higher
proliferation rates of the human lung cancer cells A549 compared to the undoped
PPy films and the glass polymer deposition substrate. Another study on PPy films
doped with RGD peptides has demonstrated a significantly higher attachment rate of
differentiated osteoblasts Giglio et al. (2000). PPy prepared with hyaluronic acid (HA) has
demonstrated excellent biocompatibility, cell attachment and growth rates in the in vitro
study with rat-derived pheochromocytoma cells (PC-12) (Kim et al., 2018). Moreover,
Kim et al. (2018) illustrate an increase in vascularization in tissues surrounding the
PPy-HA implant in the in vivo study due to the HA doped with PPy being an important
angiogenesis factor. PPy films prepared electrochemically and doped with chondroitin-4sulphate (CSA) have supported the human fibroblast cell attachment in work by Moreno
et al. (2008).
In cardiac and neural tissue engineering, where electrical stimulation of newly
formed tissues is desired, having an intrinsically conducting substrate for cell growth is
advantageous (Ferrigno et al., 2020). For example, electronic conduction through PPy
films used as a substrate for PC-12 cells has enhanced the growth and spreading of cell
neurites (Schmidt et al., 1997). Musculoskeletal tissues such as bone can also benefit
from electrical stimulation. Bone is an intrinsically piezoelectric material as it generates
potential when the load is applied (Ferrigno et al., 2020). In the study done by Zhou
et al. (2019) PPy nanocones combined with poly(vinylidene) fluoride (PVDF) polymer
were used to culture bone mesenchymal stem cells (BMSCs). PVDF was subjected to
mechanical load and has generated electronic potential that has been transmitted to
cells through PPy nanocones, and supported the attachment and growth of BMSCs.
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Conducting composites

One of the major challenges associated with application of PPy in drug delivery and
tissue engineering, is poor mechanical properties of the polymer. PPy is a brittle material
and demonstrates brittle fracture behaviour, breaking at very little elongation during
tensile testing (Murray et al., 1997). An additional drawback is the inability of PPy to be
processed into complex three-dimensional shapes (Runge et al., 2010).
Mechanical stability of the polymer can be improved through different processing
and manufacturing approaches. These include blending CPs with other polymers and
composites (Green et al., 2012). Numerous PPy blends with other materials have
been reported so far. For example, the aforementioned PPy doped with paclitaxel
was deposited through chemical oxidative polymerization on electrospun polycaprolactone (PCL) fibers (Tiwari et al., 2018). A similar approach was used to functionalize
PCL-fumarate fibers with PPy used for the electrical stimulation of PC-12 cells in a study
by Moroder et al. (2011).
Significant attention has been drawn to the conducting hydrogels (CHs). These are
hybrid materials containing conducting polymers and hydrogels. Hydrogels, discussed
in detail in the following section 2.3.1, are three-dimensional polymer networks with a
high-water content and favorable mechanical properties. The following approaches can
be used to produce conducting hydrogels: 1) in situ polymerization of a CP during the
formation of a hydrogel; 2) post-polymerization deposition of CP; and 3) a combination
of the previous two (Xu et al., 2020).
An example of a CH prepared using the one-step method is a material with selfhealing properties made through simultaneous mixing of pyrrole monomer with chitosan
powder dissolved in acetic acid and an aqueous solution of oxidizer (Xu et al., 2018).
The main drawback of this one-step process is that all components require different
solvents. Pyrrole monomer is insoluble in water, while aqueous solution is required for
the preparation of hydrophilic hydrogel (Xu et al., 2020).
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A similar approach with limited applications due to solubility issues involves incorporation of freshly synthesized CP into a hydrogel formulation prior to its cross-linking.
In the study by Guarino et al. (2013) aniline monomer with oxidizer and dopant were
dissolved in water (aniline is water soluble) and mixed with PEGDA aqueous solution
as the polymerization proceeded. This was followed by the exposure of the reaction
mixture to UV-light to initiate the cross-linking of PEGDA and to form CHs used for the
in vitro study with PC-12 cells and human mesenchymal stem cells.
Poor solubility of pyrrole leads to challenges in dispersion of the pyrrole/organic
solvent mixture or PPy particles in the hydrogel matrix. Also, incorporation of the CP in
the hydrogel precursor solution can interfere with polymerization process for hydrogels.
For example, an addition of black-coloured PPy nanoparticles in precursor solution
prior to hydrogel polymerization leads to an insufficient light absorption and impacted
solidification (Lawrence, 2021).
In contrast, the post-polymerization approach takes advantage of the poor monomer
solubility in water in combination with hydrogel hydrophilicity and includes the following
steps: firstly, a hydrogel matrix is prepared; secondly, it is infiltrated with aqueous solution
of the oxidizer (or with pyrrole monomer dissolved in the appropriate organic solvent),
and subsequently, immersed in the monomer solution (or in the oxidant solution) to
initiate the polymerization process and polymer deposition (Xu et al., 2020). As pyrrole
is insoluble in water, but oxidizers, such as ammonium persulfate, are mostly insoluble
in organic solvents, the polymerization reaction occurs at the water/organic solvent
interface in a process known as interfacial chemical polymerization (ICP) (Skotheim and
Reynolds, 2006). Although this technique is highly dependent on the diffusion rates of
polymerization components inside the hydrogel matrix (Xu et al., 2020), it provides some
level of control over the process. The deposition of the polymer on the interface inside
the hydrogel infiltrated with solutions is favoured. The ICP approach was successfully
employed in the study by Fantino et al. (2018) for the deposition of PPy inside 3D printed
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honeycomb PEGDA hydrogels.
CPs can also be deposited in the hydrogel matrix via electrochemical polymerization.
In this case, however, because hydrogel is used as a working electrode in electrochemical cell, its high conductivity has to be ensured. In the study by Green et al. (2012),
polyvinyl alcohol-heparin methacrylate (PVA-HepMA) hydrogel was polymerized on a
platinum disc electrode precoated with a poly(3,4-ethylenedioxythiophene) (PEDOT) film.
This was followed by the continued electrodeposition of PEDOT within hydrogel matrix
as polymer grew from the electrode surface coated with conducting film through the
PVA-HepMA matrix. This composite material was used for the in vitro study with neural
cell culture as a promising material for neural prosthetics. While the electrochemical polymerization process is suitable for the fabrication of biosensors and actuators, it remains
challenging to perform the deposition of PPy within complex hydrogel architectures,
such as those found in TE scaffolds.
Electroactivity of materials enabled through the addition of PPy has attracted great
interest for applications of CHs in biosensors or in neural cell culture where the conductivity property is required. However, these materials can also serve as drug carrier
components in drug delivery systems due to their capacity for oxidation/reduction upon
application of an electrical potential. CHs can also be applied as bio-instructive materials
for musculoskeletal tissue regeneration, as they support the transmission of endogenous
electrical signals between cells (Gonzalez-Fernandez et al., 2019).

2.3
2.3.1

Hydrogels
PEGDA hydrogel properties

Hydrogels are one of the most common materials to be used in scaffold design for
cartilage tissue regeneration. Hydrogels are three-dimensional polymer networks that
have cartilage tissue-like material properties. Due to their high hydrophilicity, hydrogels
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Figure 2.5: The scheme of light-sensitive polymerization of PEGDA hydrogel using the
diphenyl(2,4,6-trimethylbenzoyl)-phosphine oxide (TPO) as a PI. © Yang et al. (2015),
included with permission.
can absorb high amounts of water and provide resistance to the mechanical loads
without any damage to their structure (Wei and Dai, 2021). Hydrogels can be divided
into natural polymers (e.g. alginate, gelatin, collagen) and synthetic hydrogels ((PEG)based materials, PVA, etc.).
Among synthetic hydrogels, PEGDA has gained significant attention in recent years
for applications in drug delivery and tissue engineering due to the ease of preparation
and modification. PEGDA is a photo-crosslinkable hydrogel, meaning light stimulus
is needed to initiate the polymerization reaction. Crosslinking is induced through the
addition of biocompatible photoinitiator (PI) in the presence of light source (fig. 2.5).
Most commonly used biocompatible initiators are Irgacure 2959 and lithium-phenyl-2,4,6trimethylbenzoylphosphinate (LAP), and both can be used with the UV light sources with
wavelengths 320 nm to 390 nm (Choi et al., 2019).
PEGDA hydrogels have excellent mechanical properties which can be modulated
based on the molecular weight and concentration of PEG precursors in the polymerization solution. Nguyen et al. (2013) have demonstrated how these parameters impact
mechanical properties of PEGDA hydrogels. The confined compression modulusincreased with higher PEGDA concentrations and was in the range between 0.01 to
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2.5 MPa, similar to the values for mature articular cartilage (0.19 to 2.1 MPa). Tensile
modulus was found to be 0.02 to 3.5 MPa but was significantly lower than that of the
mature cartilage tissue (4.8 to 25 MPa) and can be improved by the addition of another
polymer or through fiber reinforcement.
Concentration and molecular weight of PEGDA precursors regulates the final crosslink
density, which ultimately dictates not only the mechanical properties, but also network
mesh size and swelling ratios. For example, in the study by Lin et al. (2011), PEGDA
hydrogels with larger mesh size stimulated chondrocyte proliferation; however, they did
not support the long-term accumulation of ECM components due to the large pore size
and had the lowest compressive modulus.
The photopolymerizable nature of PEGDA enables the fabrication of hydrogels by
means of additive manufacturing techniques, such as Stereolithography (SLA) and
Direct Light Processing (DLP). These techniques use a focused laser or light projection
onto a bath of photocurable resin and involve layer-by-layer growth of three-dimensional
polymer structures. Both SLA and DLP offer high printing accuracy and extensive
control over printing parameters and polymerization process (Mau et al., 2019). PEGDA
hydrogel scaffolds loaded with acetylsalicylic acid (ASC) have been prepared using the
SLA 3D printing method and used for the drug delivery study in the work by Vehse et al.
(2014). This study, however, showed an increase in layer thickness within the prints due
to high light penetration through the transparent PEGDA hydrogel, as well as a decrease
in compressive modulus of printed PEGDA-ASC scaffolds due to the additional loading
of drugs into the resin.

2.3.2

PEGDA hydrogel applications

PEGDA hydrogels have been previously used for encapsulation of OA derived chondrocytes and supported their growth and proliferation (Musumeci et al., 2011). They
have also been used in in-vivo studies as materials to fill cartilage defects and stimulate
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regeneration (Sharma et al., 2013). The main challenge in using these materials for
cartilage regeneration remains in promoting the attachment of stem cells to the material and their subsequent proliferation. PEG materials are intrinsically resistant to cell
adhesion and protein adsorption (Desai and Hubbell, 1991). The functionalization of
hydrogels with specific molecules providing favourable conditions for stem cells has
been proposed to overcome this obstacle, and incorporation of a co-polymer into the
hydrogel material can improve binding with biologically active substances (Tamai et al.,
2005).
PEGDA hydrogels can also be used for drug delivery. A significant work on PEGbased materials for drug release has been performed by Peppas et al. (1999). They
have concluded that the mechanism of drug release from hydrogel is based on the
diffusion of drug molecules from swollen polymer network, therefore is highly dependent
on the mesh size and porosity of a material. Drugs are usually incorporated in PEGDA
hydrogels prior to polymerization by dissolving them in the PEGDA precursor solution
Vehse et al. (2014); McAvoy et al. (2018). There are several disadvantages associated
with this process such as solubility of the drug of choice and its sensitivity to UV-light.
Post-polymerization loading through swelling of ths hydrogel in the drug solution can be
adversely impacted by the small mesh size. Therefore, creating a composite hydrogel
with a co-polymer that can perform as a drug carrier can be advantageous. In this
manner, the drug loading capacity of the composite will not depend on the microporosity
of PEGDA, and drug release can be performed in a controlled rate.

2.4

Chapter summary

This chapter provided the necessary background information related to this research
project. Structural, physiological and pathological features of cartilage tissues were
discussed in relation to challenges in cartilage regeneration. Tissue engineering has
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been introduced as a promising approach for treating cartilage tissue lesions. Finally,
electroactive conducting polymers and hydrogels have been shown to exhibit many
advantages that support their role in tissue regeneration.
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Chapter 3
Fabrication and Characterization of
Composite Poly(ethylene) Glycol
Diacrylate - Polypyrrole Hydrogels
This chapter outlines the development of a composite PEGDA-PPy biomaterial. A
multistep approach is used to incorporate conducting polymer into the photocurable
PEGDA hydrogel matrix. This process includes a UV-light-initiated crosslinking of
PEGDA, followed by the interfacial chemical polymerization of PPy. Chemical structure
and physical properties of PEGDA matrix and composite PEGDA-PPy hydrogel are
investigated. DLP 3D printing technology was used to create a porous PEGDA matrix,
subsequently used for PPy deposition. Lastly, surface morphology of PEGDA hydrogels
and PEGDA-PPy composites is compared using optical and SEM imaging.

3.1

Introduction

As described in section 2.2.4, chemical and electrochemical methods used for polymerization of pyrrole yield a polymer lacking mechanical stability. In order to exploit the
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advantageous properties of PPy and create a biomaterial having the mechanical properties required for use in regeneration of musculoskeletal tissues, it can be blended into a
composite with other polymers, such as hydrogels. This thesis explores the creation of
a biocompatible composite PEGDA-PPy material. The choice of PEGDA hydrogel as a
deposition matrix for PPy is motivated by the ease and feasibility of PEGDA preparation.
PEGDA can be polymerized through the exposure of oligomer formulation to the UV-light.
Free radicals are generated from photoinitiators added to the formulation and they start
the polymerization reaction (Uttayarat et al., 2016). UV-light is considered to be a great
external stimuli as it can be easily switched on and off and allows to control the reaction
in a timely and spatial manner (Choi et al., 2019). One of the possible drawbacks behind
using photocurable hydrogels is a possible cytotoxic effect of free radicals generated
during polymerization reaction (Fedorovich et al., 2009).
In work previously performed in the OMASML, PPy nanoparticles (PPy NPs) synthesized via oxidative chemical polymerization using the method described by Samanta
et al. (2015) were incorporated into a PEGDA hydrogel (Lawrence, 2021). This was
achieved by adding a NP suspension to a PEGDA oligomer formulation. The resulting
photocurable PEGDA-PPy NP resin formulation was exposed to UV-light to produce
biocompatible CHs used for drug delivery and cell attachment studies. Additionally, this
formulation was evaluated for the 3D printing of a bone graft model using a specialized
DLP technique developed in the OMASML.
A specially-developed additive manufacturing system located in the OMASML is
tailored to produce micro- and nanoscale features with CP resin formulations. The
important components of the printer are the DLP light engine and a vat filled with
polymer resin formulation fig. 3.1. The DLP generates light patterns which are displayed
on the liquid surface for the prescribed cure time, and selectively polymerize and solidify
polymer formulation layers (Cullen and Price, 2018). The vat then moves down leaving
the fresh layer of resin exposed to the light pattern, and the process is repeated until
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the desired geometry and architecture is produced. Cullen and Price (2018) were
able to utilize this technology to produce microscale 3D CP structures. Multi-material
resin formulation containing urethane dimethylacrylate (UDMA) as a base polymer,
pyrrole, silver nitrate and PI H-Nu 470 was used, where PI generates free radicals
which initiate polymerization reaction for UDMA and sensitize cationic initiator silver
nitrate to start the polymerization of pyrrole (Cullen and Price, 2018). A similar approach
was used in work by Cullen and Price (2019) and by Holness et al. (2021) to produce
3D CP transducers but the UDMA polymer was replaced with a blend of bisphenol A
ethoxylate dimethacrylate and polyethylene glycolmethyl ether methacrylate (BEMAPEGMA) copolymer. However, these formulations are not biocompatible due to the
addition of silver nitrate.
As described by Lawrence (2021), PEGDA-PPy NPs resin formulation was found
to be biocompatible and demonstrated good 3D printing capabilities. PEGDA resin
omitting any PPy NPs (0 %) showed significant overcuring. At the same time, other resin
formulations containing PPy NPs showed high print resolutions due to the ability of NPs
to absorb excess light. However, higher concentrations of NPs led to undercuring due to
the high rates of light absorption.
Given the limitations to PPy loading in 3D-printed structures, post-polymerization
approaches for CP deposition, namely the interfacial chemical polymerization outlined
in section 2.2.4, was chosen to prepare PEGDA-PPy samples in this work. A novel
modification to the ICP method is presented in this thesis. The conductivity and electrochemical performance of PEGDA-PPy hydrogels prepared with a modified method were
significantly improved. The chemical structure and physical properties of hydrogels such
as swelling ratio were investigated prior and following polymerization. For 3D printing
scaffolds, PEGDA resin formulation with an addition of UV-absorber was developed and
its printing capabilities were characterized prior to PPy deposition.
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Figure 3.1: DLP free-surface 3D printing technology used for the fabrication of microand nanoscale features with photopolymerizable resin formulations. © Cullen and Price
(2018), included with permission.

3.2
3.2.1

Materials and Methods
PEGDA hydrogel polymerization and characterization

To prepare the hydrogel matrix, a PEGDA formulation was developed as follows: firstly,
biocompatible photoinitiator LAP (CAS #85073-19-4) was dissolved in distilled water (DW) in an amount of 0.5 mg · mL−1 (0.05 % (w/v)). Secondly, PEGDA oligomer
formulation (average Mn 700, CAS #26570-48-9) was mixed with a LAP solution in
various PEGDA ratios: 20, 30, 40, 50, 60, 70 and 80 % (w/v). Different PEGDA concentrations were used to investigate the differences in physical properties of hydrogels. The
PEGDA formulation was then poured into a 1 cm×1.5 cm polydimethylsiloxane (PDMS)
mold and exposed to the UV-light (λ = 405 nm) for 10 min. After exposure, solidified
PEGDA samples were thoroughly washed with DW three times and left to dry overnight
before proceeding with subsequent characterization or PPy deposition.
To investigate the physical properties of PEGDA hydrogels containing different
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PEGDA concentrations, their swelling ratios (SR) in DW were evaluated. Additionally,
SRs of PEGDA in phosphate buffer saline (PBS) (pH 7.45), buffer solutions with pH
values of 8, 10, 12 and 13 were also calculated. Each sample’s dry mass was measured,
and subsequently placed in an individual vial filled with a selected solution (DW, PBS,
etc.), and left overnight. The following day, samples were carefully removed from the
solution and any excess liquid was wiped out from the surface prior to measuring the
swollen mass. Swelling ratios were calculated according to:

Swelling Ratio =

ms − md
,
md

(3.1)

where ms is the mass of the swollen hydrogel and md is the mass of the dried hydrogel
before swelling.
Based on the swelling properties of the hydrogel in DW, crosslink density was
evaluated by calculating average molecular weight between the crosslinks (Mc ,) using
the Peppas-Merrill model and formulas given below (Lee et al., 2000; Lin et al., 2011;
Koetting et al., 2015):
1
Mc

=

2
Mn

−

v̄ /V1



ln (1 − v2, s ) + v2, s + χ1 v2,2 s

v2,r



v2,s
v2,r

1/3

−

v2,s
2v2,r




,

(3.2)

where Mn is the average weight of the PEGDA (700 Mn), v̄ is the specific volume
of PEGDA (0.893 cm3 · g−1 ), V1 is the molar volume of water (18 cm3 · g−1 ), χ1 is the
Flory-Huggin’s PEG-water interaction parameter (0.426), v2,r is the polymer fraction (0.2,
0.4 or 0.8) and v2,s is the polymer volume fraction in the swollen state, as defined by:

v2,s =

1
ρ2
Qm

ρ1

+

1
ρ2

,

(3.3)

where ρ1 and ρ2 are the density of the solvent and PEGDA respectively and Qm is the
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mass swelling ratio.
Mesh sizes (ξ) of the PEGDA hydrogels were calculated according to the formula:

 1/2
−1/3
v2, s ,
ξ = r02

(3.4)

where r02 was determined by:
r02

=l

2





Mc
2
Cn ,
Mr

(3.5)

where l is a carbon-carbon bond length(0.154 nm), Cn is the rigidity factor of polymer (4
for PEG), and Mr is the molecular weight of repeating units (44 g · mol−1 for PEG).

3.2.2

PEGDA-PPy material fabrication and characterization

For the preparation of conducting PEGDA-PPy hydrogels, interfacial chemical polymerization method was used, introduced in section 2.2.4. Briefly, this method includes
subsequent submerging of PEGDA matrix in solutions of oxidizer and pyrrole. A modification of this method was introduced in this thesis to produce two different kinds of
samples, referenced below as PEGDA-PPy-a and PEGDA-PPy-b.
For PEGDA-PPy-a, dried PEGDA matrices containing 20, 40 and 80% (w/v) PEGDA
were placed in a 0.14 mol aqueous solution of the oxidizer APS (CAS #7727-54-0) for
2 h to allow the diffusion of oxidizer into the hydrogel. Samples were then removed
from the solution, excessive liquid was wiped out from their surface, and they were
carefully placed in a different vial filled with freshly distilled pyrrole monomer (CAS
#109-97-7) dissolved in cyclohexane (0.1 mol). The polymerization reaction occurs
rapidly as indicated by the colour change of the hydrogel from transparent to black.
Samples were left in a solution for an hour, then removed and any excess monomers
and solvents were washed from the surface with 70 % ethanol. Samples were then dried
overnight prior to any characterization or further studies.
For PEGDA-PPy-b, dried PEGDA hydrogels were first placed in the solution of
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pyrrole, followed by the soak in APS solution. The molarity, solvents, reaction time,
and post-polymerization wash remained the same as for the PEGDA-PPy-a. Reversing
polymerization steps in this case was found to yield samples with different surface
morphology.
The polymer product of ICP was also produced separately. In a beaker, 5 mL of
the 0.14 mol aqueous solution of APS were combined with 5 mL of 0.1 mol of pyrrole in
cyclohexane under constant magnetic stirring. The reaction happens immediately and
results in the precipitation of insoluble PPy particles. Particles were paper-filtrated and
washed with ethanol, then left to dry in the fume hood overnight. This method has also
been used to prepare PPy particles doped with Fl for the drug delivery studies reported
in section 4.2.
To confirm incorporation of a conducting component into the inert hydrogel matrix,
the electrical conductivity of dried samples was measured with a four-point probe
method using a Keithley 2611 source meter and a custom MATLAB script. Voltage
measurements were taken over a span of 50 s from 3 different locations on 3 samples.
The following equation was used to calculate conductivity:

σ=

I ln 2
,
π ∆V t

(3.6)

where σ is the apparent conductivity, I is the current applied between the first and fourth
electrodes, ∆V is the recorded voltage drop between the second and third electrodes
and t is thickness.
PEGDA hydrogels, PPy powder and PEGDA-PPy-a samples were analyzed with
Fourier transform infrared (FTIR) spectroscopy using a Bruker Tensor II spectrometer. Swelling ratios of PEGDA-PPy samples were measured and calculated using the
methodology described above for PEGDA hydrogels (section 3.2.1) to investigate the
impact of a second polymer fraction on the physical properties of the composite.
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Figure 3.2: A three-electrode electrochemical cell used for cyclic voltammetry. Current is
applied to the stainless steel counter electrode (CE), and the response is collected from
the PEGDA-PPy working electrode (WE). © Taha et al. (2020), included with permission.
To evaluate the electrochemical performance of PEGDA-PPy hydrogels, cyclic voltammograms were recorded. Samples were connected to the source meter and used as
working electrodes (WE) in a 3-electrode electrochemical cell also containing a stainless steel counter electrode (CE) and a silver-silver chloride reference electrode (RE)
(fig. 3.2). The electrochemical cell was filled with a 0.1 mol aqueous sodium nitrate
(NaNO3 ) solution, and the potential was cycled between −0.5 V to 1.5 V for 5 cycles at a
scan rate of 20 mV · s−1 .
The surface morphology of the PEGDA, PEGDA-PPy-a and PEGDA-PPy-b samples
was analyzed by means of a Keyence VHX-7000 digital microscope and Field Emission
Scanning Electron Microscopy (FESEM).
All data was collected in triplicate (n=3) unless stated otherwise, to determine
mean values and their associated standard deviations (±). One-way analysis of variance (ANOVA) and multiple comparison tests were performed using MATLAB.
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3D printing

3D printing of PEGDA hydrogels was performed using the additive manufacturing technology outlined in section 3.1. 3D structures were produced using the custom-designed
OMASML DLP printer, which has an emission wavelength of 385 nm, irradiation energy
of 7.37 J · cm−3 , and a theoretical minimum XY feature resolution of 5 µm. Prior to printing, depth of cure (DoC) tests were performed on several resin formulations to select
the best formulation and establish the optimal layer cure time and layer thickness for
3D printing. All characterized PEGDA resin formulations contained 40 % (w/v) PEGDA,
and 0.1 or 0.05 % (w/v) of LAP, and 0.5 , 0.75 , or 1 % (w/v) of UV-absorber Orange G
dye (Sigma Aldrich Cat. #O3756). UV-absorbance of resin formulation components was
collected using the Cary-60 spectrometer.
DoC experiments were performed as follows: a metal vat was filled with resin and
covered with a transparent plastic microscope slide, so that there was a direct contact
between the slide and the top layer of resin liquid. A metal vat was placed directly
under the light engine of the printer and the light pattern illustrated in fig. 3.9 (a) was
projected onto the slide for 5 s for the 0.1 % (w/v) LAP resin formulation, and for 10 s for
the 0.05 % (w/v) LAP formulation. Six square features are projected on the first layer,
and one feature is removed from the projection image with each subsequent exposure.
In this way, every feature of the pattern is cured for a different amount of time creating
varying layer thicknesses. The thickness of printed features was measured with Keyence
VHX-7000 digital microscope, and correlated with UV-absorber concentrations creating
a logarithmic trendline (y = m1 ln x + C), where average depth of cure was defined as
the slope value m1 .
Following DoC tests and resin formulation selection, the following parameters were
prescribed for 3D printing: 100 µm layer thickness and 40 s cure time. Four base layers
of unpatterned film and one additional base layer of features, each cured for 120 s,
were required due to printer setup to avoid variations in first layer thicknesses. To test
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feature resolution that can be achieved with selected resin formulation, pattern outlined
in fig. 3.10 (a) (adapted from Thingiverse #2011862) was printed. Other print models
were designed using either the SolidWorks or nTopology software (fig. 3.11 (a–b)).

3.3

Results and Discussion

3.3.1

PEGDA hydrogel properties

The swelling ratio is an important physical parameter defining permeability of hydrogels. For in vivo applications, swelling properties define the material allowance for
nutrient/waste exchange. Swelling properties are also closely related to structural and
mechanical properties. The mass swelling ratio is used to calculate polymer volume
fraction in the swollen state - a parameter used to quantify average molecular weight
between the crosslinks (Mc ). Mc determines mechanical strength of hydrogels (Lin et al.,
2011). Hydrogels with high Mc values usually exhibit low compressive moduli but high
ultimate strength. Hydrogel porosity is quantified through the mesh size parameter
defined as an average linear distance between crosslinks (Koetting et al., 2015). Mesh
size is a parameter that has been found to influence cell behavior. In the study by Lin
et al. (2011), PEGDA hydrogels with larger mesh sizes have demonstrated increased
chondrocyte proliferation rates, however, limited accumulation of ECM components.
These physical parameters can be controlled by varying the molecular weight of
PEGDA precursor or by changing precursor concentration in polymerization solution. In
this study, the latter approach was selected to investigate changes in physical properties.
Variations in swelling, Mc and mesh sizes were chosen as ways to control drug release
rates from PEGDA-PPy hydrogels.
The swelling ratios of PEGDA hydrogels with different PEGDA content are compared
on fig. 3.3 (a). There was a statistically significant difference in SR values between
samples with low PEGDA concentrations (20, 30, 40 and 50 % (w/v)). For example,
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SR of PEGDA (20 %) was determined as 204±14 %, which is a double increase from
the SR of PEGDA (40 %) 111±5 %. There was also a statistically significant difference
between the low PEGDA concentration group of samples and hydrogels with high
PEGDA concentrations (60, 70 and 80 % (w/v)), however, there was no significant
difference in swelling ratios within the last group. Thus, PEGDA (60 %) had a SR value
of 83±1 %, and PEGDA (80 %) an SR of 68±2 %. It is likely that within the sample group
where PEGDA occupies more than a half of a material volume, changes in polymer
concentration do not significantly contribute to the swelling properties. Moreover, swelling
ratio values for this group of samples were ≤ 100 %. Similar trends have been observed
for Mc and mesh size values, which are tabulated in table 3.1.
As expected, PEGDA (20 %) demonstrated the highest values for SR, Mc and mesh
size parameters, therefore, this hydrogel should have the lowest compressive modulus
but high permeability. PEGDA (40 %) hydrogel was selected to proceed with for the
majority of experimental studies as it demonstrated good swelling and physical properties
withing the group of hydrogels investigated. Given the statistically significant difference
in swelling ratios between PEGDA 20, 40 and 80 % (w/v) (One-way ANOVA, F=10.19 ,
p=0.0049 ), these samples were selected for the study of controlled drug release.
As the drug release studies in this work are performed in a media with physiological
pH values but also in alkaline media to stimulate release from PPy, it was necessary
to first identify the swelling properties of PEGDA hydrogel in these media. Swelling
ratios of PEGDA hydrogels in solutions with different pH values are presented on fig. 3.3.
Hydrogel swelling greatly impacts the diffusion of the drug from the polymer. The swelling
ratio of PEGDA (40 %) in pH 13 was significantly higher from SRs in other solutions:
373±41 % compared to 122±1 % in PBS and 171±13 % in pH 12 buffer solution (Oneway ANOVA, F=88.48 , p=9.18·10−8 ). It has been reported that a slight increase in
swelling ratios of PEGDA hydrogels can be seen in buffers with high pH values (Cavallo
et al., 2017). This observation is linked to the hydrolytic degradation of PEGDA in
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MW between the crosslinks (Mc )

Mesh size (ξ)

PEGDA content

Mean ±Standard deviation

Mean ±Standard deviation

20
40
60
80

67.03±9.35
55.58±4.13
54.65±1.12
55.27±2.17

0.79±0.07
0.64±0.03
0.61±0.08
0.59±0.01

Table 3.1: Average molecular weight between adjacent crosslinks and mesh sizes of
PEGDA hydrogels with different concentrations of PEGDA (% (w/v)), calculated using
the Peppas-Merrill model.
alkaline media (Browning et al., 2014; Browning and Cosgriff-Hernandez, 2012).

3.3.2

PEGDA-PPy characterization

Incorporation of PPy within the PEGDA hydrogels was achieved through the interfacial
chemical polymerization method. Physical and structural properties of the composites
were evaluated, firstly, to confirm the incorporation of PPy, and secondly, to explore the
impact of PPy on PEGDA. Figure 3.4 demonstrates the FTIR spectra collected from PPy,
PEGDA and PEGDA-PPy samples. It can be clearly seen that PEGDA-PPy spectra
closely resembles PEGDA except for the band at 1565 cm−1 , which can be also found
in the PPy spectra. This band is related to the vibration of single- and double- C–C
bonds in the pyrrole ring, demonstrated on fig. 3.4 (b) (Tabaciarova et al., 2015). This
confirmed the successful deposition of PPy on PEGDA hydrogels.
Swelling ratios of PEGDA-PPy were not significantly different compared to PEGDA.
PEGDA(40 %)-PPy had a SR of 110±15 %, and PEGDA(80 %)-PPy SR was 67±14 %.
These values are similar to SR values for PEGDA hydrogels, listed in section 3.3.1.
Therefore, an incorporation of PPy did not impact the permeability of hydrogel matrix.
The results from conductivity measurements of PEGDA, PEGDA-PPy-a and PEGDAPPy-b samples are presented in table 3.2. PEGDA hydrogels are non-conductive
materials, and the deposition of PPy led to a significant increase in conductivity for
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(a)

(b)

(c)
Figure 3.3: The swelling properties of PEGDA hydrogels depending on the PEGDA
content (% (w/v)) (a), pH of the solution (b), deposition of PPy (c). Data points represent
mean values ±standard deviation.
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Conductivity, S · cm−1
PEGDA
PEGDA-PPy-a
PEGDA-PPy-b

(2.95±0.62)·10−11
(3.70±0.15)·10−9
(2.3±2.1)·10−4

Table 3.2: The average conductivity of PEGDA, PEGDA-PPy hydrogels prepared with
standard (PEGDA-PPy-a) and modified (PEGDA-PPy-b) methods, data presented as
mean value ±standard deviation.
PEGDA-PPy samples (unpaired t-test, p ≤ 0.0001). Interestingly, there was also an increase in conductivity for PEGDA-PPy-b samples compared to PEGDA-PPy-a, however,
it was not statistically significant (unpaired t-test, p = 0.007).
Cyclic voltammetry (CV) was performed on PEGDA-PPy samples prepared with two
ICP methods. Graphs representing the first CV cycles for both materials are shown in
fig. 3.5. When the potential is scanned from high (positive) values to low (negative), the
reduction reaction occurs meaning the loss of electrons from PPy. Then the potential is
increased and polymer is oxidized. It can be clearly seen that PEGDA-PPy-b sample
demonstrates higher magnitude in reduction. This is likely due to the higher amounts
of PPy being deposited on the surface of PEGDA-PPy-b compared to other samples.
Increased surface area provides an increased number of doping sites, where electron
exchange is more readily possible. This improved electrochemical performance of
PEGDA-PPy samples prepared with modified ICP method is important for applications
in sensors and actuators, and also for drug delivery. As previously mentioned in
section 2.2.2, electrochemical doping is one of the most common methods used for drug
incorporation with PPy. An improved electrochemical performance of PEGDA-PPy-b
samples prepared with chemical methods and primary doped with oxidizer anions could
allow for dedoping (reduction) in electrochemical cell followed by the doping (oxidation)
with the drug dopant of choice.
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(b)

Figure 3.4: FTIR spectra of PEGDA, PPy and PEGDA-PPy (a). The band peak at
1565 cm−1 in PEGDA-PPy indicates a presence of double and single carbon bonds
characteristic for pyrrole ring in the structure of PPy (b). © Gelmi et al. (2014), included
with permission.

Figure 3.5: Cyclic voltammorgams of PEGDA-PPy-a and PEGDA-PPy-b demonstrating
higher magnitude in reduction for PEGDA-PPy-b.
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Surface morphology

As mentioned in section 3.2.2, changing the sequence of solutions for PEGDA immersion during interfacial chemical polymerization process yielded samples with different
surface morphologies: PEGDA-PPy-a and PEGDA-PPy-b. These differences were
first evaluated with optical microscopy and the pictures are presented on fig. 3.6. The
surface of PEGDA-PPy-a looks smooth compared to PEGDA-PPy-b. The morphology
of PEGDA-PPy-b indicates the presence of a rough PPy film covering the hydrogel. To
further investigate surface structure of the composites, FESEM was performed. Microscopy pictures are presented on fig. 3.7. The typical globular cauliflower appearance
of PPy can be seen in both PEGDA-PPy-a and PEGDA-PPy-b compared to the smooth
PEGDA surface. PEGDA-PPy-b has large clusters of PPy polymer on the surface which
are clearly charging when an electron beam from a microscope is applied. Overall,
FESEM confirms optical microscopy findings and indicates that larger amount of PPy is
accumulated on the surface of PEGDA-PPy-b. Improved electrochemical performance
and higher conductivity of PEGDA-PPy-b discussed in section 3.3.2, therefore, can be
explained by the high surface area.
The reason for the differences observed in surface morphologies is attributed to the
method of preparation. For PEGDA-PPy-a materials, PEGDA is placed in an aqueous
solution of oxidizer and then in the organic solution of pyrrole. PEGDA matrix swells
very well in an aqueous media and adsorbs oxidizer in its structure. When the solution
is changed to pyrrole, polymerization and PPy deposition preferentially occur within the
structure of a hydrogel. In the case of PEGDA-PPy-b, the hydrogel is first placed in
the organic solution of pyrrole, which does not penetrate the PEGDA pores as well as
water, and therefore the pyrrole monomer accumulates within superficial layers. When
the solution is changed to APS, nucleation sites for PPy polymerizaton occur primarily
on the surface, leading to higher levels of polymer deposition within superficial layers.
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(a)

(b)

(c)

(d)

Figure 3.6: Optical microscopy pictures of PEGDA-PPy-a (a) and PEGDA-PPy-b (b)
samples demonstrating variations in surface morphologies due to differences in fabrication methods. Cross-section images of PEGDA-PPy-a (c) and PEGDA-PPy-b (d)
indicate that PPy has been sucessfully deposited through the thickness of PEGDA
hydrogel using either of ICP methods. Scale bar represents 500 µm.
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(a)

(b)

(c)
Figure 3.7: Scanning electron microscopy pictures of PEGDA-PPy-a, demonstrating
typical for PPy cauliflower surface morphology (a); PEGDA-PPy-b, demonstrating high
amounts of deposited polymer (b); and PEGDA hydrogel with smooth unmodified
surface (c).
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Figure 3.8: UV-absorbance of PEGDA resin components. The vertical line indicates
printer emission wavelength λ = 385 nm.

3.3.4

3D printing

Previous studies on SLA and DLP 3D printing with PEGDA formulations have demonstrated the need for controlling the depth of light penetration in order to produce complex
geometries and overhanging structures (Mau et al., 2019). An addition of UV-absorber
is a common approach to reduce the depth of light penetration from the printer’s light
source. This allows the selective curing of the exposed layer of resin without simultaneous overcuring of the printed layers below, in addition to the realization of overhanging
structures. Selection of the Orange G dye for the UV-absorber is motivated by the
biocompatibility of the compound (Sinh et al., 2016).
As previously mentioned in section 3.2.3, the OMASML printer light source emission
wavelength is 385 nm. From the fig. 3.8 it can be clearly seen that the absorbance
of both LAP and Orange G dye at 385 nm is > 0, indicating the activity of the listed
components at this wavelength.
Depth of cure tests were necessary to determine the optimal concentrations of LAP
and UV-absorber in the formulation, and to select printing parameters. The results of the
DoC test are presented in table 3.3. As expected, the DoC is decreasing with increasing
concentrations of Orange G dye absorber. Additionally, there is an increase in DoC value
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UV-absorber, % (w/v)

Depth of cure, µm

0.05

0.5
0.75

93.1
29.9

0.1

0.5
0.75
1

127.8
61.3
36.4

Table 3.3: The depth of cure values for PEGDA resin formulations containing different
concentrations of PI (% (w/v)), and UV-absorber (% (w/v)).
for the 0.1 % (w/v) LAP resin formulations compared 0.05 % (w/v) LAP resin containing
the same concentrations of the absorber. This finding can be explained by an increase
in the speed of photopolymerization reaction due to higher concentrations of initiator.
A PEGDA resin formulation containing 0.1 % (w/v) LAP and 0.5 % (w/v) Orange G
dye with a DoC value of 127.8 µm was selected for 3D printing. It is important to mention,
that change of printing setup from DoC experiment to free surface printing fig. 3.1 (a)
can slow down the rate of polymerization reaction during light exposure due to the
consumption of free radicals generated by PI in oxygen. Therefore, the actual depth of
cure value could decrease, and therefore the layer thickness printing parameter was
prescribed as 100 µm.
Printing the DoC pattern (fig. 3.9(a)) using the conventional printer setup has demonstrated no overcuring in the XY-plane fig. 3.9 (b). Each printed layer can be visualized
separately and layer thickness varied between 81 µm to 96 µm, which is attributed to the
rapid drying and shrinkage of PEGDA. To demonstrate the ability to create overhanging
structures using the selected resin formulation, a thin film was printed across the span
of two supporting structures fig. 3.9 (c).
Resin printing resolution was explored through printing pillar structures of different
diameters fig. 3.10 (a). It can be clearly seen on fig. 3.10 (b) that it was only possible to
print pillars with diameters > 400 µm. Only one layer of smaller diameter pillars (250 µm,
300 µm and 350 µm) could be printed. This is likely due to the insufficient stiffness of
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the PEGDA 40 % (w/v) resin formulation. However, achieved resolutions are sufficient
for tissue engineering applications.
In light of these results, a pillar diameter of 500 µm was selected for printing of tissue
engineering scaffold models. This pillar pattern was printed with a 500 µm distance
between pillars, shown on fig. 3.10 (c), to demonstrate that this distance allows for a
sufficient outflow of liquid resin when the vat moves up and down in between the layers.
Resin entrapment between the structures could lead to overcuring. Additionally, printing
the two-layer film on top of the pillars was also successful, thus creating a basis structure
for the tissue engineering scaffold model fig. 3.10 (d).
A tissue engineering scaffold model was created using the nTopology software
fig. 3.11 (a–b) and represented the array of 500 µm pillars evenly spaced (500 µm)
and connected together with a lattice structure at the base, middle and at the top.
Distances between support lattice structures were also 500 µm, yielding a final pore size
of 500 µm×500 µm. An optical micrograph of the porous PEGDA scaffold is presented
in fig. 3.11 (c). Pore size measurements were performed in both the swollen (directly
after printing) and dry states. In the swollen state the horizontal distance between the
pillars varied between 603 µm to 607 µm, and 450 µm to 495 µm vertically. In the dried
state these dimensions were 560 µm to 605 µm and 450 µm to 479 µm respectively. This
structure was used for the interfacial chemical polymerization of pyrrole, yielding the
PEGDA-PPy scaffold presented in fig. 3.11 (d). Print dimensions have been preserved
after the deposition of PPy.
Biomaterial scaffolds are responsible for structural support and integrity of the TE
complex, and they also have to provide enough space for the formation and growth of
new tissue. The gold standard is that the material occupies ≈ 25 % of the structure
volume, while ≈ 75 % is left open (Aisenbrey et al., 2018). In order to achieve these
parameters with the PEGDA formulation, the stiffness issue can be addressed through
increasing PEGDA concentration and varying LAP and UV-absorber content accordingly.
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(a)

(b)

(c)
Figure 3.9: Pattern used for the DoC tests where features in white are being projected
as images (a); 3D print testing the layer printing height based on the DoC pattern (b);
3D print testing printing of overhanging structures (c). Scale bar represents 500 µm.
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(a)

(b)

(c)

(d)

Figure 3.10: Pillar pattern used for the resolution test (a); printed pillar resolution test
pattern (b); the array of pillars 500 µm in diameter printed on a 2-layer base film (c);
the array of pillars 500 µm in diameter printed in a 6-layer base film with a 2-layer film
printed on top (d). Scale bar represents 500 µm.
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(a)

(b)

(c)

(d)

Figure 3.11: The model of a lattice structure created using nTopology software (a-b);
PEGDA lattice 3D-printed as a tissue engineering scaffold model (c); PEGDA-PPy
scaffold created after PPy deposition on to the previous PEGDA structure using the ICP
method. Scale bar represents 500 µm.
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Chapter summary

This chapter described the fabrication process for composite conducting PEGDA-PPy
hydrogels. A photopolymerization reaction was implemented to prepare a PEGDA hydrogel matrix used for the deposition of PPy via interfacial chemical oxidative polymerization.
Structural and physical properties of PEGDA and PEGDA-PPy were then investigated.
Lastly, 3D printing capabilities of PEGDA resin using the custom-designed OMASML
DLP printer were discussed. The results presented in this chapter establish that this
methodology for the creation of electoactive conducting PEGDA-PPy tissue engineering
scaffolds is viable.
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Chapter 4
Drug Incorporation and Delivery from
the Composite PEGDA-PPy Hydrogels
This chapter explores the drug delivery capabilities of composite PEGDA-PPy hydrogels.
Doping of anionic compounds with PPy during chemical oxidative polymerization is
discussed. Drug release was performed in Phosphate Buffer Saline solution with
physiologically relevant pH and in alkaline media to facilitate the expulsion of the drug
from the PPy component. Control over the drug release rates was achieved through
variations in PEGDA matrix density and is presented in this chapter.

4.1

Introduction

Conducting polymers have been extensively investigated as potential candidates for
localized drug delivery applications (Tandon et al., 2018). The interest in using PPy for
drug delivery comes mainly from the electroactivity of the polymer. The ability of PPy
to change its structural (doping/de-doping with ionic compounds) and physical (shape,
volume) properties in a response to electrical stimuli was recognised as a promising
strategy for drug release or biological sensor applications.
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Section 2.2.2 outlines mechanisms involved in drug loading and release from CPs,
namely PPy. The majority of studies exploring CPs for drug delivery applications rely
on the doping performed through electrochemical oxidation/reduction of the polymer
(Tandon et al., 2018). During chemical oxidative polymerization, incorporation of a
dopant is possible, however, is usually limited to small anionic species coming from
the oxidizer (Wallace et al., 2002). This chapter aims to explore doping of PPy with
anionic compounds during chemical oxidative polymerization, and possible limitations
associated with this process.
Although electrical stimulation has been very effective in delivering doped drugs from
PPy in the experimental setup (Uppalapati et al., 2016), there is an ongoing search for a
feasible in vivo release stimulus. Samanta et al. (2015) have performed a study on drug
delivery from PPy NPs stimulated by changes in pH of the environment. Deprotonation
reaction of PPy in the alkaline media, briefly described in section 2.2.2, caused expulsion
of the doped drug. Samanta et al. (2015) also describe successful dopant release at
physiological pH values (7.4). Lawrence (2021) has also demonstrated dopant release
from PPy NPs over the physiological pH range (6 to 8). In this chapter, alkaline media
(pH 11.2) was used to trigger release of a drug from PEGDA-PPy hydrogels to confirm
dopant incorporation. Release of the dopant from PEGDA-PPy in the Phosphate Buffer
Saline (pH 7.4) was also investigated.

4.2

Materials and Methods

To demonstrate the potential of PPy to perform as a drug carrier in composite PEGDAPPy hydrogels, PPy was doped with a model anionic compound, Fluorescein sodium
salt (Fl) (CAS #2321-07-5). The doping process was performed during the interfacial
chemical polymerization described in section 3.2.2. Fl (0.04 mol) was dissolved in
an aqueous solution of the oxidizer, APS. Oxidizer molarity was reduced to 0.1 mol
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to facilitate the doping of PPy with Fl. Dried PEGDA hydrogels were placed in the
oxidizer-dopant solution for 2 h and then transferred in to the solution of pyrrole (0.1 mol)
in cyclohexane. After polymerization was completed, PEGDA-PPy-Fl samples were
gently rinsed with ethanol and left to dry overnight. The pH of the solutions employed
for the polymerization and doping were monitored with the Mettler Toledo benchtop
pH-meter throughout the process.
Two control groups of samples: PEGDA-Fl and PPy-Fl were prepared to study the
release of Fl separately from the PEGDA matrix and the polymer PPy. For PEGDAFl, PEGDA hydrogels were soaked in an aqueous solution of Fl for 2 h, rinsed with
distilled water and dried overnight. PPy powder doped with Fl was prepared using the
methodology described in section 3.2.2. An aqueous solution of APS 0.1 mol and Fl
(0.14 mol) was mixed with 0.1 mol of pyrrole in cyclohexane resulting in the precipitation
of CP particles. The particles were paper-filtrated from the polymerization mixture,
quickly rinsed with ethanol and dried overnight prior to the experiments. All samples
were protected from the light after preparation and during release studies. Both PEGDAFl and PEGDA-PPy-Fl hydrogels had an equal surface area of 2.7 cm2 .
Drug release studies were conducted in Phosphate Buffer Saline (PBS, pH 7.4)
and in 0.01 mol aqueous solution of NaOH (pH 11.2). Experimental (PEGDA-PPyFl) and control samples (PEGDA-Fl or PPy-Fl) were placed in 3 mL of the release
media. The mass of PPy-Fl for release studies was measured as 0.08 g. Absorbance
data from release media was collected using a Cary 60 UV-vis spectrometer at 2 h
of release. Fl concentrations in release solutions for each sample were calculated
using the collected absorbance data and standard curve method. Fl has a pH-sensitive
maximum absorbance value Guern et al. (2020), therefore, separate standard curves
were prepared for Fl in PBS and NaOH solutions.
For the controlled drug delivery experiment, PEGDA hydrogels with PEGDA concentrations of 20 % (w/v), 40 % (w/v) and 80 % (w/v) were prepared for PPy deposition to
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explore the influence of the hydrogel matrix density on Fl release rates. PPy polymerization was performed as previously outlined. Release studies were performed using the
0.01 mol NaOH solution (pH 11.2). Each sample was placed in 5 mL of release media,
and 20 µL of the media was drawn every 30 min over a span of 8 h. The total decrease
in the release media volume by the final time-point was 2.4 % and was considered
negligible. A media sample was dissolved in 1 mL NaOH solution for UV spectrometry.
Fl concentrations were back-calculated using the standard curve method.
All data was collected in triplicates (n=3), unless stated otherwise, to calculate
average values and standard deviations (±). One- or two-way analysis of variance
(ANOVA) and multiple comparison test were performed in MATLAB.

4.3
4.3.1

Results and Discussion
Drug doping with PPy during chemical polymerization

During chemical oxidative polymerization of PPy, small anions arising from oxidizer (for
example, persulfate anions in the case of APS), could be doped with PPy much easier
than any other added anionic compounds (Wallace et al., 2002). Also, an addition of
oxidizer could impact the structural properties of Fl. These factors were explored and
are reported below.
Following the steps of doping with Fl during chemical oxidative polymerization,
PEGDA matrix was subsequently submerged in aqueous solution of oxidizer with Fl, and
then in cyclohexane containing pyrrole monomer. The mole ratio of the dopant:pyrrole
was 0.4:1, and oxidizer:pyrrole ratio was 1:1. According to Wallace et al. (2002), the
ideal oxidizer:pyrrole ratio is 1.3:1 for two-electron oxidizers (e.g. APS) to allow the two
electrons provided by the oxidizer to efficiently incorporate pyrrole monomers within the
polymer. Every 3rd or 4th pyrrole unit is then doped with an anion for electrochemical
neutrality. For drug doping, the oxidizer concentration was reduced to prevent the
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Figure 4.1: Ionic forms of Fl depending on the pH of the environment. Di-anionic form of
Fl existing at neutral pH levels and giving the maximum absorbance at 490 nm is transforming into mono-anionic and further into neutral and cationic forms with a progressive
acidification of the environment. This is followed by the decrease in fluorescence and
maximum absorbance peak shifting to the left. (© Guern et al. (2020) included with
permission)
competitive incorporation of persulfate ions along with Fl.
The pH of Fl/APS solution was found to be 2.7. According to Guern et al. (2020),
acidification of the solution can lead to the transformation of anionic form of Fl into
the neutral or cationic form (fig. 4.1). As previously described in section 2.2.1, PPy
doping implies incorporation of anionic species into the polymer chain to balance out an
excessive positive charge of as-synthesized PPy (Tandon et al., 2018). Cationic and
neutral forms of Fl are unlikely to act as counter ion dopants for PPy. However, in the
chemical doping process used in this study, change of solution to pyrrole/cyclohexane
with a pH of 7.7 was done to reverse this effect.
For drug delivery studies, alkaline pH media was used as a release stimulus. PPy
in alkaline media undergoes a deprotonation reaction specific for this polymer. As
previously described in section 2.2.2, PPy has an excessive amount of hydrogen ions,
which are linked with anionic dopants to maintain the stability of the polymer backbone.
When the polymer is placed in the environment with low hydrogen ion concentration (high
pH), it causes the expulsion of H+ from the backbone, along with the dopants (Samanta
et al., 2015). Therefore, an increase in Fl release rates from PPy and PEGDA-PPy in
alkaline solution would indicate that Fl performed as a dopant.
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Figure 4.2: 2 h Fl release from PPy, PEGDA-PPy and PEGDA hydrogels in PBS and
NaOH solution (pH 11.2). Higher release rates in alkaline media can be seen for all
samples, indicating deprotonation reaction of PPy causing the expulsion of a dopant,
and increased swelling of PEGDA in high pH media.
Alkaline media (pH 11.2) caused significant differences in Fl release rates compared to release in PBS for all three sample groups, and yielded significantly different
results between control and experimental sample groups as well (pH 7.45), (Two-way
ANOVA, F=179.4, p=1.4·10−8 ) as shown in fig. 4.2. PEGDA-PPy samples released
only 0.57±0.20 µg · mL−1 of Fl in PBS, but 4.67±0.59 µg · mL−1 in NaOH solution. It was
also seen that Fl release rates for PEGDA hydrogels were slightly higher in the NaOH
solution compared to PBS: 2.02±0.13 µg · mL−1 and 1.58±0.21 µg · mL−1 respectively.
This can be explained by the increased rate of swelling of PEGDA in alkaline solutions
previously described in section 3.3.1. Although, increased rate of PEGDA swelling might
contribute to higher rates of Fl release in PEGDA-PPy samples, overall, PEGDA-PPy
samples released statistically significantly higher Fl amounts in alkaline media than
PEGDA samples (One-way ANOVA, F=79.78, p=8.76·10−9 ). This significant difference
indicates the deprotonation reaction of PPy and proves an incorporation of Fl in PPy as
a dopant. Additionally, drug delivery performance of PPy fabricated and doped with Fl
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using the same chemical oxidative polymerization method confirms these findings.
The absorbance values collected at 490 nm from the PPy-Fl samples were in the negative range: −0.024 to −0.028, indicating the absence of Fl. In contrast, the absorbance
values collected from NaOH solution were ranging between 0.207 to 0.328, yielding the
average Fl concentration released from PPy to be 1.43±0.35 µg · mL−1 . Physiological
pH values do not cause deprotonation of the polymer. According to Pei and Qian (1991),
the pKa value for the deprotonation of PPy is in the range of 9 to 11. Given this, it is
unlikely that PPy will release anionic dopants in physiological media without external
stimulation. However, PEGDA-PPy hydrogels have demonstrated low Fl release levels
in PBS likely contributed by the diffusion of undoped Fl from PEGDA matrix. For drug
delivery purposes, PEGDA-PPy hydrogels can provide the immediate dose of the drug
through the diffusion from PEGDA matrix, followed by the delivery of higher doses from
stimulated PPy.
Given the infeasibility of alkaline pH stimuli for the delivery of anionic drugs from PPy
in vivo, other triggers need to be investigated. External electrical stimulation causing
reduction of the polymer and dopant release is theoretically possible, however, has
not yet been studied in vivo. Another promising external stimuli for drug release from
PPy is a near-infrared(NIR) radiation. In the study by Tiwari et al. (2018) the NIR laser
exposure has caused the delivery of anti-tumour drug paclitaxel (PTX) from PPy-coated
polycaprolactone fibers.
Low acidic pH values are more common in vivo. For example, gastric juice has a pH
value ranging from 1.0 to 3.0, or inflammation can lower the pH of the tissues (5.4 to 7.4)
(Koetting et al., 2015). According to Samanta et al. (2015), release of positively-charged
drugs is possible from PPy in the acidic media via protonation reaction of the polymer
(section 2.2.2). Therefore, investigating the incorporation of positively charged drugs
into PPy, and their release in acidic media is advised for future research.
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Controlled drug release from PEGDA-PPy hydrogels

Additional control over the rates of Fl release from PPy was achieved through variations
in PEGDA matrix density. The results of this experiment are presented in fig. 4.3.
PEGDA-PPy hydrogels with PEGDA content of 20, 40 and 80% were selected for this
study based on the statistically significant differences in swelling ratios discussed in
section 3.3.1. Overall, the set of samples used for this experiment achieved significantly
higher Fl release rates than samples used in the previous tests.
It can be clearly seen that PEGDA(20 %)-PPy hydrogels demonstrated the fastest
rate of Fl accumulation due to the lowest matix density. For example, the 2 h Fl release
concentration for PEGDA(20 %)-PPy was 35.40±0.68 mg · mL−1 , what was significantly
higher than the Fl concentrations of 23.62±1.65 mg · mL−1 and 27.39±0.98 mg · mL−1 for
PEGDA(40 %)-PPy and PEGDA(80 %)-PPy hydrogels respectively (One-way ANOVA,
F=78.71, p=4.94·10−5 ). The speed of Fl accumulation during the first 2 h of release
(the difference between 2 h and 30 min Fl amounts) was statistically significant between PEGDA(20 %)-PPy and two other sets of samples (One-way ANOVA, F=75.38,
p=5.6·10−5 ), but not between the latter. Thus, the amount of Fl accumulated from
PEGDA(20 %)-PPy was 17.26±0.50 mg · mL−1 , while for PEGDA(40 %)-PPy it was
only 8.14±1.48 mg · mL−1 . Interestingly, over the next 6 h, Fl release speed from
PEGDA(40 %)-PPy was significantly higher (21.30±0.36 mg · mL−1 ), while PEGDA(20 %)PPy demonstrated the lowest rate of Fl accumulation (15.16±1.40 mg · mL−1 ; One-way
ANOVA, F=39.14, p=0.0004).
PEGDA(80 %)-PPy samples overall showed similar to PEGDA(40 %)-PPy trends for
Fl release speed: only 9.48±0.65 mg · mL−1 for the first 2 h and 17.90±0.33 mg · mL−1 for
the following 6 h. Although, as previously mentioned, the 2 h Fl amounts were statistically
higher for PEGDA(80 %)-PPy than for PEGDA(40 %)-PPy.
The 24 h Fl release amounts were statistically significant between PEGDA(80 %)-PPy
and PEGDA(40 %)-PPy & PEGDA(20 %)-PPy (One-way ANOVA, F=71.06, p=6.65·10−5 ).
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Figure 4.3: Fl release from PEGDA(20 %)-PPy, PEGDA(40 %)-PPy and PEGDA(80 %)PPy, data collected over a span of 8 h with 30 min increments. PEGDA(20 %-PPy
demonstrates the fastest release rate due to the low hydrogel density allowing for easy
drug diffusion. Data points represent meaan values ±standard deviation.
Final release values are presented in table 4.1. Higher final amount of Fl released
from PEGDA(80 %)-PPy could indicate the higher Fl loading for 80 % sample. Additionally, there was a significant difference between 8 h and 24 h Fl release values
for PEGDA(40 %)-PPy and PEGDA(80 %)-PPy samples (One-way ANOVA, F=120.86,
p=7.79·10−10 ), but no significant difference was seen for PEGDA(20 %)-PPy. This means
that PEGDA-PPy hydrogels will allow for more gradual release of the drug.
An approach of controlling drug release rate from hydrogels by tuning the matrix
density has been previously described in the study by Shirakura et al. (2017). There,
hydrogel NPs with loose matrix have demonstrated a faster rate of drug release over 75 h
period. In the new study by Briggs et al. (2022), polyacrilamide hydrogel matrix density
was increased using two different approaches: by adding higher amounts of polymer,
and through increasing concentrations of the crosslinker. In both cases, reduced
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24 h Fl release
Sample

Fl concentration (mg · mL−1 )

PEGDA(20%)-PPy
PEGDA(40%)-PPy
PEGDA(80%)-PPy

55.49±1.37
52.72±1.31
63.25±0.41

Table 4.1: Fl release values collected from PEGDA(20 %)-PPy, PEGDA(40 %)-PPy and
PEGDA(80 %)-PPy hydrogels at 24 h presented as mean values ±standard deviation
drug release rates were demonstrated associated with higher hydrogel crosslinking
density, regardless of the intitial drug loading. In the case of composite CHs, hydrogel
matrix mitigates the initial burst release of drug from the PPy. For example, in the
work by Samanta et al. (2015), PPy NPs were dispersed in calcium alginate hydrogel
for the sustained release of piroxicam. The long-term delivery study from hydrogel
demonstrated a much slower rate of piroxicam accumulation compared to NPs.
As previously discussed in section 3.3.1, PEGDA(20 %) had significantly higher
swelling ratio and mesh size than PEGDA(40 %) and PEGDA(80 %). This is first to our
knowledge study investigating the relationship between PEGDA crosslink density and
drug release rates from PPy incorporated into hydrogel matrix. Low matrix density and
higher distance between the polymer chains in PEGDA(20 %) facilitates the permeability
of hydrogel and diffusion of Fl released from PPy deposited within the matrix. By varying
PEGDA hydrogel matrix density, different levels of control over release rate could be
achieved for PEGDA-PPy materials.

4.4

Chapter summary

This chapter has demonstrated successful doping of PPy with anionic compound Fl
via oxidative chemical polymerization. Drug release from PEGDA-PPy was initiated in
solutions with alkaline and physiological pH values. This chapter describes stimulation
of dopant release in relation to in vivo applications. Control over drug delivery rates
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was achieved through varying concentrations of PEGDA precursor leading to different
matrix densities of PEGDA-PPy material. These results have demonstrated the viability
of PEGDA-PPy materials for sustained drug delivery and unlock new research directions
for various types of dopant molecules and release triggers.
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Chapter 5
Biocompatibility of PEGDA-PPy
Hydrogels and Application for
Cartilage Cell Attachment
This chapter explores the biocompatibility of PEGDA and composite PEGDA-PPy hydrogels. Cytotoxicity testing was performed according to ISO Protocol #10993: Biological
evaluation of medical devices. Protein adsorption and cell attachment to biomaterials
were investigated to explore the potential application of PEGDA-PPy in cartilage tissue
engineering.

5.1

Introduction

Every material before placed into contact with biological tissues or cellular environment
should meet the biocompatibility requirements. Most importantly, biomaterials should
not cause any toxic or immunological reactions in vivo. However, biocompatibility
of a material in its broad definition, is not just an absence of cytotoxicity, but also
characterises a capacity of a material to interact with in vivo environment (Lotfi et al.,
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2013).
Adhesion of cells to the surface of biomaterial is a requirement for cell delivery and
tissue regeneration. This is a complex process including the formation of focal adhesion
points through cell adhesion proteins (i.e. fibronectin, laminin etc.), cell signaling, and
possible alterations of the biomaterial. Biomaterial factors involved in this process
are chemical composition, surface roughness, and electric charge (Lotfi et al., 2013).
Surface morphology specifically plays an important role as it not just provides a substrate
for cell attachment, but also could have a specific effect on cell behaviour (Cai et al.,
2020). On rough surfaces, cells form many focal attachment points and the arrangement
of cytoskeleton is usually followed by the production of extracellular matrix proteins. This
information encoded in protein and gene sequences is passed to other cells, therefore,
cell and subsequently tissue phenotype are changed (Boyan et al., 1996). Additionally,
surface morphology governs the hydrophilicity and wettability of the material, which are
the properties important for protein adhesion (Lotfi et al., 2013).
In biomaterial design, functionalization with factors that promote cell adhesion and
proliferation is a vital consideration for a material that is involved in tissue regenerative
processes (Bellis, 2011). The indirect functionalization approach involves enhancing
protein adsorption to the biomaterial. The direct approach implies grafting of a biomaterial surface with peptides and growth factors stimulating cell adhesion (Mcfarland et al.,
2000). Surface morphology modifications have been also explored for promoting cell
attachment. Specifically, in the area of metal bone and dental implants, many chemical
and mechanical surface modifications were exploited to enhance adhesion of bone cells
(Zareidoost et al., 2012).
As previously described in section 2.3.1, PEGDA hydrogels do not provide a supportive environment for cell attachment and need to be modified with bioactive molecules for
tissue engineering applications (Choi et al., 2019; Zhu, 2010). PPy as a biocompatible
co-polymer in the structure of PEGDA-PPy composite materials, offers many advanta-
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geous properties. In the study by He et al. (2017), the typical cauliflower appearance
of the polymer has been found to be beneficial for the attachment of osteoblastic cell
line. In work by Lawrence (2021), PEGDA hydrogels containing PPy NPs demonstrated
increased rates of pre-osteoblast cell adhesion, and cells were preferentially adhered to
PPy, stretching between the the clusters of NPs.
In section 3.3.3 SEM pictures of PEGDA-PPy hydrogels prepared with interfacial
chemical polymerization (ICP) method have demonstrated different surface morphologies compared to PEGDA hydrogels, and between two ICP methods. Therefore, it
was hypothesized, that an addition of PPy would allow for protein adsorption and cell
attachment to PEGDA, and increased surface roughness of PEGDA-PPy-b materials
would enhance the biocompatibility.

5.2
5.2.1

Materials and Methods
Cytotoxicity testing

Cell culture media was prepared by combining Dulbecco’s Modified Eagle Medium/Nutrient Mixture F-12 (DMEM/F-12) (ThermoFisher Cat. #11330032), 10 % fetal bovine
serum (FBS) (ThermoFisher Cat. #12483020) and 1 % Penicillin-Streptomycin (ThermoFisher Cat. #15140122) followed by sterile filtration. ATDC5 chondrogenic cells
derived from mouse teratocarcinoma were used in this experiment (Yao and Wang,
2013).
PEGDA and PEGDA-PPy-a hydrogels were prepared in triplicates. Prior to cytotoxicity testing, samples were thoroughly washed with 70 % ethanol three times and
left in ethanol overnight for sterilization. The following day, samples were transferred
to the bio-safety cabinet where they were washed twice with Dulbecco’s phosphatebuffered saline (DPBS) (ThermoFisher Cat. #14190144) for 10 min, followed by a cell
culture media soak for 30 min. Each sample was then moved into an individual well of
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a 24-well cell culture plate. The average surface area of each sample in swollen state
was determined as 2.7 cm2 based off the casting molds used. According to the ISO
10993-12: Section 10.3.3, for samples with thickness ≤ 1 mm, 1 mL of media is required
for a sample with surface area of 3 cm2 . Therefore, 900 µL of full cell culture media was
added to each well containing sample. This media specifically contained DMEM/F-12
without phenol red (ThermoFisher Cat. #21041025). Polymers were incubated at 37 °C
for 14 d, 7 d, 72 h and 24 h. Hydrogel soaking periods were staggered-started so that all
media would reach the desired time-point on a single day when the ATDC5 cells reach
80 % confluency.
Two days prior to the end of the hydrogel media soaking period, ATDC5 cells were
passaged into 96-well plates with a density 2500 cells/well (passage n=3). Three plates
were created where cells at different passages were plated (n=4, 5 or 6) to create three
biological replicates. Additionally, two triplicates of the following cell densities: 500 ,
1000 , 2500 , 5000 and 7500 cells/well were plated, to build the standard curve through
matching the absorbance values from the XTT assay to the cell counts. Standard
curves were created separately for each biological replicate. When cells reached 80 %
confluency, original cell culture media was replaced with 100 µL of the cell culture
conditioned by hydrogel soaking. Negative control wells had 35 µmol of the Sodium
Dodecyl Sulfate (SDS, Sigma Aldrich Cat. #151213) solution in culture media. Positive
control well contained fresh cell culture media (no phenol red). Three wells were left
blank. ATDC5 cells were left to incubate for 24 h.
The next day, the XTT Cell viability assay was performed according to the manufacturer’s protocol (ThermoFisher Cat. #X12223). 2 mL of the Electron Coupling Reagent
was added to 12 mL of XTT solution and vortexed. The solution was used immediately
by adding 70 µL to each test well and one of the standard curve well groups. Plates
were left to incubate for 4 h at 37 °C. Following incubation, the plates were transferred
to the TECAN Safire plate reader. Absorbance values were collected at 450 nm for XTT
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absorption and at 660 nm for background absorbance. Specific absorbance and cell
viability were calculated using the following formula:

Absorbance = Abs450 (Test) − Abs450 (Blank) − Abs660 (Test)

% Viability =

Abs450 (Test) − Abs660 (Test)
× 100%
Abs450 ((+) Control) − Abs660 ((+) Blank)

(5.1)
(5.2)

The second group of standard curve wells was used for cell counts. To each well
30 µL of trypsin (0.25 w/v solution) was added, followed by short incubation (4 min) and
neutralization with 70 µL of cell culture media. Cells were counted with a hemocytometer
and cell numbers were matched to the XTT absorbance values from the first group
of standard curve wells. Prior to performing cell counts, the representative images
of ATDC5 cells cultured at 2500/well density were taken with a Leica Phase Contrast
Microscope.
Average cell viability and cell count values along with the standard deviations were
calculated using the data from 3 biological replicates (3 plates with cells at different
passage n), triplicates for each hydrogel type, and 3 technical replicates (total n=27).
One-way analysis of variance (ANOVA) and multiple comparison test were performed in
MATLAB.

5.2.2

Protein adsorption and cell attachment

To test the adsorption of proteins to hydrogels, PEGDA, PEGDA-PPy-a, and PEGDAPPy-b were soaked in protein solutions for either 2 h or 24 h in triplicates. The negative
control group contained samples soaked in DPBS for 24 h. Two different protein solutions
were used: Bovine Serum Albumin (BSA) (ThermoFisher Cat. #0023210) and FBS. At
designated time points, samples were rinsed with DPBS to remove any loosely bound
proteins, and put in the 1 % SDS solution in DPBS. Samples were placed on a rocker
mixer for 2 h to facilitate the elution of proteins in SDS. The Pierce TM Rapid Gold BCA
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Protein Assay Kit (ThermoFisher Cat. #A53225) was used to measure the amount of
protein adsorbed. 20 µL of the SDS solution from each sample was mixed with 200 µL of
the working reagent from the kit. Cu+ ion in the working reagent is reduced by the protein
in an alkaline media resulting in the orange-gold reaction product. The absorbance of
the reaction product was collected using a TECAN Safire Plate Reader at 480 nm, and
protein concentrations were calculated using the standard curve obtained with BSA
standard solutions. One-way analysis of variance (ANOVA) of the absorbance data and
multiple comparison test were performed to in MATLAB.
For a cell attachment study, PEGDA, PEGDA-PPy-a and PEGDA-PPy-b samples
were prepared in disc shapes, with a diameter of 15 mm and 1 mm thickness to cover
the well in the 24-well plate. Samples were soaked in 70 % ethanol overnight and the
next day were transferred into the bio-safety cabinet. Each sample was placed in the
individual well of the 24-well plate, washed with DPBS twice for 10 min and then 1 mL
of cell culture media was added. Samples were incubated in the media for 2 h in 37 °C
to facilitate the adsorption of proteins to the surface. The next day, ATDC5 cells were
passaged and 200 µL of cell suspension was placed on the sample surface achieving
the final plating density of 5000 cells/cm2 . Additionally, cells were plated on to tissue
culture plastic at the same density to create a positive control well. Samples with cells
were incubated for 1 h at 37 °C to allow cells to attach to the surface, and then 800 µL
of media was added to achieve the final volume of 1 mL in each well. Samples with
cells were left to incubate for 3 d, and then cell fixation was performed. Firstly, cell
culture media was aspirated, followed by double rinsing with PBS. Then, 0.5 mL of
4 % (w/v) of polyformaldehyde (PFA) solution was added to each well. After 10 min PFA
was removed and samples were washed with PBS again. To visualize the actin fibers
of cells, staining with Alexa Fluor 488 Phalloidin was performed (Invitrogen Cat. #
A12379). Firstly, blocking solution (1 % BSA in PBS) was applied to cells for 30 min
followed by washing with PBS twice for 5 min each. Then, 20 µL of stock Phalloidin
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was dissoved in 800 µL of PBS and 100 µL of diluted stain was added to each well and
incubated for 20 min at room temperature with agitation. After incubation the stain was
removed and wells were washed with PBS. To visualize cell nuclei, Hoechst staining
was performed as follows: 0.5 mL of 1 µg · mL−1 of Hoechst stain (Sigma Aldrich Cat.
#33342) was added to each well and the plate was kept on a rocker mixer for 20 min at
room temperature, protected from light. After staining, Hoechst solution was removed,
samples were washed with PBS twice for 10 min, then fresh PBS was added to each
well to keep samples hydrated during imaging. Cells were imaged with a Leica DMI6000
microscope.

5.3
5.3.1

Results and Discussion
Cytotoxicity testing

The results of the biocompatibility testing for PEGDA hydrogels and PEGDA-PPy conducting hydrogels are summarized in fig. 5.1 and table 5.1. Positive control wells where
cells were cultured in fresh media, were taken as 100 % viability. Figure 5.2 (a) is a
phase contrast image of healthy ATDC5 culture from the positive control well. The
ISO Protocol #10993: Biological evaluation of medical devices defines cytotoxicity as

≤ 70 % cell viability (ISO 10993-1:2018, 2018). Cytotoxic effects of SDS solution can be
clearly seen in the negative control wells, where cells only demonstrated 22 % viability.
A representative phase contrast image of the cell culture well treated with SDS is shown
in fig. 5.2 (b).
Overall, media extracts from PEGDA and PEGDA-PPy samples did not show any
cytotoxic effect on ATDC5 cells. Average cell viability for PEGDA-PPy samples ranged
from 77 % (24 h) to 137 % (7 d). A decrease in cell viability for a short time-point was not
significantly different from the positive control, and was higher than 70 % viability level
that indicates cytotoxicity. Possible sources of cytotoxicity are solvents and uncured
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Figure 5.1: Viability of ATDC5 cells treated with media extracts from PEGDA and
PEGDA-PPy hydrogels calculated from XTT assay using the eq. (5.2). Average viability
(%) is plotted with the standard deviation. Total n of data points used = 27 = (3 technical
replicates X 3 of each hydrogel type) X 3 biological repetitions of the test with cells at
different passages. There was no significant difference between sample groups and
time-points compared to the positive control (100 %), indicating no cytotoxic effect.
monomers entrapped in polymer network which should be effectively washed out from
PEGDA-PPy with ethanol. A slight decrease in cell viability for a short time media soak
could indicate an insufficient washing, however, the viability levels did not indicate any
cytotoxicity. Importantly, due to the non-degradable nature of PEGDA-PPy materials,
longer time-points for polymer media soak were introduced in this biocompatibility study.
It can be clearly seen in fig. 5.1 that cell viability slightly increased for longer polymer
exposure times.
Average cell viability for PEGDA hydrogels was not significantly different from
PEGDA-PPy, and was ranging from 97 % (14 d) to 141 % (7 d). A major concern for the
biocompatibility of PEGDA hydrogels comes from the possible toxic effects of PI used
for cross-linking and free radicals generated during the polymerization reaction. The PI
used for PEGDA polymerization in this study, LAP, is cytocompatible (Choi et al., 2019).
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(a)

(b)

Figure 5.2: Phase contrast images taken at 10× magnification of positive control well from
XTT viability study representing healthy ATDC5 cell culture plated at 2500 cells/well (a),
and negative control well representing dead cells treated with SDS solution (b). Scale
bar represents 200 µm.
Cell Counts (Mean ±Standard Deviation)
Sample

24 h

72 h

7d

14 d

PEGDA-PPy
PEGDA

4 934±4 445
9 370±10 271

10 985±10 033
10 901±7 450

11 712±8 486
12 894±11 882

11 364±7 975
7 160±5 533

Table 5.1: Calculated cells/well from the XTT specific absorbance data using the plated
standard curves to create a linear formula relating absorbance to cell numbers. No
statistical difference was seen between any time-points or types of samples. Results
are reported with the standard deviation. Total n of data points used = 27 = (3 technical
replicates X 3 of each hydrogel type) X 3 biological repetitions of the test with cells at
different passages. Mean values were rounded to the nearest hundredth.
In the study performed by Fairbanks et al. (2009) 96 % survival rate was reported for
fibroblasts encapsulated in PEGDA hydrogels photo polymerized using the LAP initiator.
The results of the XTT study confirm the absence of any cytotoxic effect in the media
extracts taken from PEGDA hydrogels.

5.3.2

Protein adsorption and cell attachment

Proteins adsorbed to the surfaces of PEGDA, or PEGDA-PPy hydrogels can be extracted
from samples following SDS detergent treatment and detected using the BCA Protein
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Assay kit. Figure 5.3 demonstrates no significant difference between absorbance values
of the extract solutions from experimental samples and negative control group samples.
There is also no significant difference in absorbance values between the two different
types of proteins used (FBS or BSA) or in the duration of exposure of samples to protein
solutions. Given the similar absorbance values of solutions that do not contain protein
(negative control group) and solutions expected to contain protein (experimental sample
group), it was concluded that no protein was extracted from hydrogel samples. Therefore,
absorbance values have not been converted into protein concentrations.
Protein adsorption to the surface of TE scaffolds is an important step preceding cell
attachment (Moroder et al., 2011). PEGDA hydrogels as PEG derivatives are intrinsically
resistant to protein adsorption and, therefore, do not support cell attachment (Choi et al.,
2019). PPy, on the other hand, has been utilized as a substrate for cell attachment in
numerous studies, as described in section 2.2.3. Schmidt et al. (1997) demonstrated
improved interactions of PC-12 cells with PPy films. This study described enhanced
cell attachment as a result of increased adsorption of positively-charged proteins to
the negatively charged surface of PPy films. In the study by Moroder et al. (2011),
polycaprolactone fumarate-PPy scaffolds have demonstrated the adsorption of proteins
and nerve growth factor from the media. However, it is important to mention, that in both
studies PPy has been doped with large anionic dopant: poly(styrenesulfonate) (Schmidt
et al., 1997), naphthalene sulfonic acid (NSA) or dodecylbenzene sulfonic acid (DBSA)
(Moroder et al., 2011), which according to Schmidt et al. (1997) are responsible for the
high surface negative charge of materials.
PEGDA-PPy hydrogels used for the protein adsorption study in this thesis did not
contain any dopants, except for the persulfate ion coming from the APS oxidizer during
polymerization. The absence of large anionic dopants may have been a potential
drawback which can be addressed in future studies.
Differences in surface morphology between PEGDA-PPy-a and PEGDA-PPy-b
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(b)

Figure 5.3: Mean absorbance values (± standard deviation) of SDS solutions used for
the extraction of FBS (a) BSA (b) proteins from PEGDA, PEGDA-PPy-a, and PEGDAPPy samples immersed in protein solutions for 2 h or 24 h. No significant difference
was observed in absorbance values between samples and negative control group
representing materials immersed in DPBS, indicating the absence of protein in SDS
extracts.
have been hypothesized to influence the adhesion of proteins and, subsequently, cell
attachment. However, as mentioned earlier, no proteins were detected in extract
solutions from either of samples. Additionally, it is possible that the conditions of SDS
solution treatment were insufficient to lift proteins from sample surfaces. Park and Bae
(2002) investigated the properties of poly(ethylene oxide) (PEO) and poly(tetramethylene
oxide) (PTMO) copolymer coatings for use in hemocompatible devices where protein
adsorption to materials is undesirable. In this study, for the detection of proteins adsorbed
to PEO/PTMO, samples were submerged in BSA, followed by sonication in 1 % SDS
solution for 30 min to achieve maximum SDS-protein binding. It is likely that sonication
may be required to facilitate the detachment of proteins from PEGDA-PPy hydrogels as
well.
Fluorescent images of positive control well, PEGDA and PEGDA-PPy hydrogels with
fixated cells collected at low magnifications (5×) are presented on fig. 5.4. Nuclei of
ATDC5 cells can be clearly visualized on PEGDA-PPy-a samples (fig. 5.4 (a)). It can
also be seen that cells are organized in clusters of two or three. The amount of cells
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(a)

(b)

(c)
Figure 5.4: Fluorescent images of Hoechst stained PEGDA-PPy-a (a), PEGDA hydrogels (b) and TCP (c). ATDC5 cell nuclei can be visualized on the surface of PEGDAPPy-a materials and tissue culture plastic indicating successful cell attachment. Scale
bar represents 500 µm.
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(a)

(b)

Figure 5.5: Hoechst and phalloidin stained ATDC5 cells adhered to PEGDA-PPy-a (a).
Actin fibers stained with phalloidin (green) are extended from the centre of the cell with
nucleus (stained blue) indicating the formation of attachment points on the material.
Scale bar represents 100 µm (a) and 50 µm (b).
attached to PEGDA-PPy-a samples is significantly lower than number of cells adhered
to tissue culture plastic (fig. 5.4 (c)). As expected, no cells were attached to the surface
of PEGDA hydrogel (fig. 5.4 (b)). Interestingly, PEGDA-PPy-b hydrogels have also
demonstrated no cell attachment. The morphology of cells attached to PEGDA-PPy-a
and stained with both the nuclear Hoechst stain and phalloidin actin stain is presented
on fig. 5.5. It can be clearly seen that cells have several attachment points, however,
actin fibers are mostly concentrated around the nuclei.
An addition of PPy to PEGDA hydrogel has led to the successful attachment of
ATDC5 cells to the material. As described in section 2.2.3, PPy has been investigated
as a substrate for cell adhesion and overall has demonstrated high attachment rates for
cardiac progenitor cells (Gelmi et al., 2014), osteoblasts (Giglio et al., 2000a), and human
fibroblasts (Moreno et al., 2008). An improvement of pre-osteoblast cell attachment to
PEGDA hydrogels was previously achieved through the addition of PPy nanoparticles in
the work by Lawrence (2021). This thesis is a first study describing successful adhesion
of cartilagenious ATDC5 cells to PEGDA-PPy hydrogels.
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The absence of cell adhesion on PEGDA-PPy-b could be a result of the increased
surface roughness of the material as opposed to the initial hypothesis. In general,
material roughness at micro- and nanoscale are considered to be the most successful in
promoting cell adhesion and growth (Cai et al., 2020; He et al., 2017). In the study done
by Kay et al. (2004), improved osteoblast and chondrocyte adhesion was seen on PLGA
film surfaces with nanometer roughness dimensions compared to micron dimensions. It
is likely that the roughness of PEGDA-PPy-b did not support cell attachment. Additionally,
as discussed in section 3.3.3, surface morphology has a direct impact on surface free
energy and wettability. These parameters also affect adsorption of proteins and help
to stabilize the formed protein complexes (Lotfi et al., 2013). Future studies could
investigate contact angle and hydrophilicity parameters of PEGDA-PPy-a and PEGDAPPy-b hydrogels.
Direct functionalization of PEGDA-PPy materials with cell adhesion peptides or other
proteins is also a promising method to enhance cell attachment and proliferation on
scaffolds. For example, the amino acid sequence arginine-glycine-aspartate also known
as RGD-peptide which is naturally present in the structure of ECM poteins, have been
extensively investigated for grafting of biomaterials (Bellis, 2011). Electrochemically
deposited PPy films have been previously doped with RGD peptide in studies by Giglio
et al. (2000b); Li and Yu (2017), and have demonstrated significantly higher levels of
osteoblast cell attachment than to non-modified films (Giglio et al., 2000b). Future
studies can investigate grafting of PEGDA-PPy with RGD peptide through the doping
during chemical polymerization. An improved electrochemical performance of PEGDAPPy-b described in section 3.3.2 should also allow for electrochemical doping and can
ensure higher drug loading.

C HAPTER 5. PEGDA-PP Y

5.4

88

BIOCOMPATIBILITY

Chapter summary

This chapter described the biocompatibility testing of PEGDA hydrogels and PEGDAPPy composite materials. Both types of materials demonstrated the absence of any
cytotoxic effect on ATDC5 cells over the 14 d period. The absence of cytotoxicity confirms
the safety of photo-crosslinking and interfacial chemical polymerization methods used
for material fabrication. Although, protein adsorption study did not yield any positive
results, successful attachment of ATDC5 cells to PEGDA-PPy was demonstrated. Future
studies could focus on qualitative characterization of the attached cells. Modifications of
PEGDA-PPy such as PPy doping with anionic compounds or peptides could be explored
as a method to facilitate protein adsorption and cell adhesion.
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Chapter 6
Concluding remarks

6.1

Summary of conclusions

This thesis explored the fabrication of composite PEGDA-PPy hydrogel biomaterials for
regenerative cartilage applications. The knowledge ascertained through these studies
has prompted the following conclusions:
1. PPy can be successfully incorporated into hydrogels using the interfacial chemical
polymerization method. PEGDA hydrogel can serve as PPy deposition matrix,
and its physical and mechanical properties, and ultimately the properties of the
composite material, can be controlled through varying degrees of hydrogel crosslinking during the photopolymerization of PEGDA. PPy incorporation does not
affect the permeability of the hydrogel, moreover, PEGDA-PPy conducting composites demonstrated the capacity for oxidation/reduction reactions. Novel ICP
methods was developed to enhance the electrochemical performance and create
distinctive surface morphology.
2. A PEGDA resin formulation was developed for the use in the OMASML stereolithography printer, and was successfully applied for the fabrication of porous
structures. It was shown that ICP methods can be used to incorporate PPy into 3D
92
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printed structures to create tissue engineering scaffolds with enhanced bioactivity
due to the addition of PPy.
3. PPy can be successfully doped with anionic molecules during the chemical oxidative polymerization while being deposited on to PEGDA hydrogel matrix. pHdependant drug release from PEGDA-PPy material was demonstrated. Drugs
incorporated with the composites can be released in solutions at physiologically
relevant pH values. PEGDA hydrogels provide an additional level of control over
the drug release by slowing down the diffusion of the drug.
4. Finally, biological testing of PEGDA-PPy demonstrated the absence of cytotoxic
effect from the material extracts, and indicated improved cell adhesion of ATDC5
cartilaginous cells onto the material surface compared to PEGDA hydrogels alone.

6.2

Summary of contributions

The most significant research contributions presented in this thesis are summarized as
follows:
• The first-ever study that introduces a customization of interfacial chemical polymerization as a method to improve electrochemical properties and modify surface
morphology of PEGDA-PPy hydrogels for biomedical applications.
• A novel study on the properties and printing parameters of PEGDA resin for
stereolithography. Developed resin formulation was applied to fabricate porous
lattice structures that serve as a basis for tissue engineering scaffold models. ICP
methods were applied to 3D printed porous structure to fabricate PEGDA-PPy
electroactive scaffold with resolutions relevant for tissue engineering applications.
• The first to our knowledge study to explore the doping capability of PPy via
chemical oxidative polymerization. Novel research on pH-dependant drug release
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from PEGDA-PPy demonstrated a contribution of PEGDA hydrogel matrix to the
drug release rates in alkaline solutions.
• The first study to explore the biocompatibility of PEGDA-PPy materials with cartilaginous cells ATDC5. Biological study results demonstrated no cytotoxicity and
indicated cell adhesion onto the surface of conducting hydrogels. A novel approach
to surface modification for PEGDA-PPy hydrogels during chemical polymerization
for the improvement of cell attachment has been introduced.

6.3

Recommendations for future research

This thesis is a thorough study on ICP as a method for the drug doping of PPy and
its incorporation into the hydrogel matrix. The modification to this method introduced
in Chapter 3 led to the fabrication of PEGDA-PPy samples with significantly different
electrochemical properties and surface morphologies. Further investigation is needed
to expand the knowledge about the conductivity, drug doping and delivery properties of
these materials. Contact angle and wettability measurements would help to predict and
explain protein and cell adhesion onto surfaces. Additionally, achieving good control
over the amount of PPy deposited on the surface could help to further modify surface
morphology of PEGDA-PPy materials and obtain optimal parameters for cell attachment.
Developed PEGDA resin formulation has been successful for applications in 3D printing of lattice structures with subsequent PPy deposition for the creation of electroactive
tissue engineering scaffolds. Further tuning of the formulation would be to increase the
PEGDA concentration to improve the stiffness for the printing of smaller scale features.
Drug release studies demonstrated the ability of PPy in PEGDA-PPy composites
to be doped with anionic compounds. Future studies could investigate of doping of
PPy with cationic molecules. Due to the capacity of PEGDA-PPy materials for oxidation
and reduction under the action of electic potential, reported in this thesis, doping in an
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electrochemical cell could be possible to achieve higher rates of drug loading. Testing
dopant release over a pH range commonly found in the human body, as well the
application of other in vivo relevant release stimuli should be explored.
The expansion to the cell attachment study is needed to investigate the interactions
between cells and material surface. Gene expression testing could be done to the cells
adhered onto the material and stimulated into cartilaginous differentiation. This would
help to understand if the material supports cell activities such as protein synthesis vital
for the formation of the new tissue.
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